Introduction {#s1}
============

Plasmodesmata (PD) function as the intercellular channels in plants and are important for the growth and development of plants, as well as during their interaction with the surrounding environment ([@bib9]; [@bib33]; [@bib37]; [@bib38]; [@bib39]). The density and size of PD are developmentally controlled ([@bib60]), which allows the formation of spatial symplastic domains in order to establish tissue-specific developmental programs. The permeability of PD must be precisely regulated at specific times during plant growth and development. However, the mechanisms that tightly regulate the permeability of PD are largely unknown.

The actin cytoskeleton has been implicated in intercellular communication via PD ([@bib1]; [@bib6]; [@bib45]; [@bib58]). In support of this notion, actin and some actin-associated proteins were demonstrated to localize to PD ([@bib15]; [@bib19]; [@bib47]; [@bib55]). However, due to technical problems, the existence of filamentous actin in PD remains controversial, as does the nature of its organization. This has been a barrier to our understanding of the function of the actin cytoskeleton in the regulation of cell-to-cell trafficking via PD. In addition, to date, most of the data regarding the function of actin at PD have been obtained from experiments using actin-based pharmacological treatments, which showed that destabilization of actin filaments increases the permeability of PD, whereas stabilization of actin filaments decreases it ([@bib17]; [@bib53]). Given that these actin drugs non-selectively target the actin cytoskeleton within cells, it is hard to assess whether and to what extent the changes in PD permeability depend on the alteration in PD actin dynamics. In view of this point, specific manipulation of the actin dynamics at PD via genetic means is an ideal approach, although it requires the identification of PD-localized actin or actin-associated proteins that can serve as the target for the genetic manipulation. Nevertheless, previous observations suggest that the presence and dynamics of the actin cytoskeleton are indeed vital for intercellular trafficking via PD. For example, an interesting study showed that *Cucumber mosaic virus* (CMV) Movement Protein (MP) behaves like an actin-binding protein (ABP) that severs and caps actin filaments in vitro and its filament severing activity is required for its function in increasing the size exclusion limit (SEL) of PD ([@bib53]). The authors therefore argued that actin filaments at PD function as a filter to control the permeability of PD ([@bib6]). The study of Chen et al. also suggests that some endogenous ABPs may be involved in regulating actin dynamics at PD and consequently in controlling the permeability of PD.

Formin (formin homology protein) is one type of actin nucleation factor that has been implicated in the generation of linear actin bundles ([@bib5]; [@bib7]; [@bib31]). The formin proteins are characterized by the presence of formin homology domain1 (FH1) and FH2, which are capable of nucleating actin assembly from actin or actin-profilin complexes ([@bib5]; [@bib7]; [@bib31]). There are numerous formin genes in plants ([@bib5]; [@bib13]). For instance, the *Arabidopsis* genome contains 21 formin genes that are divided into two classes: 11 members in Class I, which encode proteins that contain the characteristic transmembrane (TM) domain except *Arabidopsis* formin 7; and 10 members in Class II, which encode proteins without a TM domain but carry an N-terminal phosphatase and tensin-related (PTEN)-like domain ([@bib5]; [@bib14]). The Formin proteins have been implicated in numerous actin-based cellular processes in plants, such as polarized pollen tube growth and root hair growth, cell division, cytokinesis and cell morphogenesis, and plant defense ([@bib8]; [@bib20]; [@bib30]; [@bib35]; [@bib61]; [@bib62]; [@bib63]). However, it remains largely unexplored how different formin proteins evolve and adapt to various actin-based cellular functions in plants.

Here we demonstrate that AtFH2, along with several Class I formins, localizes to PD and is involved in the regulation of cell-to-cell trafficking via PD. The PD-localization pattern of AtFH2 is determined by its TM domain. Interestingly, we found that several rice Class I formins also target to PD, suggesting that the involvement of Class I formins in regulating actin dynamics at PD may be evolutionarily conserved in plants. We showed that AtFH2 caps and stabilizes actin filaments in vitro, which allows us to propose that AtFH2 regulates actin dynamics and cell-to-cell trafficking by anchoring and stabilizing actin filaments at PD. Loss of function of *AtFH2* increases PD permeability, which supports the notion that the stability and/or the amount of actin filaments at PD is crucial for their role in regulating intercellular trafficking. Our study thus adds formin as an important component of the actin-mediated machinery that regulates PD permeability.

Results {#s2}
=======

Loss of function of *AtFH2* does not cause overt developmental defects in *Arabidopsis* {#s2-1}
---------------------------------------------------------------------------------------

To determine the physiological functions of *AtFH2* (At2g43800), two T-DNA insertion mutants of *AtFH2* were obtained and analyzed ([Figure 1---figure supplement 1A](#fig1s1){ref-type="fig"}). They were shown to be knockout alleles since the full-length *AtFH2* transcript is absent in both *atfh2* mutants ([Figure 1---figure supplement 1B,C](#fig1s1){ref-type="fig"}). However, no overt developmental defects were observed in young seedlings and mature plants of *atfh2* mutants ([Figure 1---figure supplement 1D](#fig1s1){ref-type="fig"}). This might be due to functional redundancy among *Arabidopsis* formin genes. However, considering that *Arabidopsis* formin genes exhibit distinct tissue expression patterns and their encoded proteins are quite diverged ([@bib13]), they likely perform some distinct and specialized functions that cannot be uncovered by simply examining the morphology of seedlings and adult plants.

AtFH2 localizes to PD in a manner that depends on its TM domain-containing N-terminus {#s2-2}
-------------------------------------------------------------------------------------

Determination of the intracellular localization of AtFH2 may provide hints regarding whether AtFH2 performs specialized cellular functions. We therefore generated an eGFP fusion construct of *AtFH2* driven by its own promoter (*AtFH2p:AtFH2-eGFP*) and demonstrated that it is fully functional (see below), which suggests that AtFH2-eGFP will faithfully indicate the intracellular localization of AtFH2. Initial observations revealed that AtFH2-eGFP decorates dot-like structures along the borders of cells ([Figure 1---figure supplement 2A](#fig1s2){ref-type="fig"}). Given that AtFH2 contains a TM domain, we speculated that the AtFH2-decorated dot-like structures may be located on the plasma membrane. In partial support of this speculation, the AtFH2-eGFP-decorated structures overlap with the staining of propidium iodide (PI) ([Figure 1---figure supplement 2B](#fig1s2){ref-type="fig"}), a nucleic acid binding dye that cannot cross the membrane of living cells and consequently stays outside the membrane, thus revealing the contours of cells. Interestingly, the AtFH2-eGFP-positive dot-like structures are reminiscent of PD. To demonstrate this, we performed callose staining, which has been used previously to detect PD ([@bib4]; [@bib12]; [@bib23]). We found that the AtFH2-eGFP-decorated structures overlap with dot-like structures revealed by callose staining ([Figure 1A](#fig1){ref-type="fig"}). This result was extended by showing that AtFH2 colocalized with two PD markers, PDLP1-GFP ([Figure 1B](#fig1){ref-type="fig"}; \[[@bib54]\]) and YFP-PDCB1 ([Figure 1C](#fig1){ref-type="fig"}; \[[@bib51]\]). Thus, the data demonstrate unambiguously that AtFH2 localizes to PD.

![AtFH2 localizes to plasmodesmata and its PD localization is determined by the TM-containing N-terminus.\
(**A**) Images of AtFH2-mCherry and callose (stained with aniline blue) in *Arabidopsis* epidermal pavement cells and the merged image. (**B**) Images of AtFH2-mCherry and PDLP1-eGFP in *Arabidopsis* epidermal pavement cells and the merged image. (**C**) Images of AtFH2-mCherry and YFP-PDCB1 in *Arabidopsis* epidermal pavement cells and the merged image. (**D**) AtFH2-eGFP, CMV MP-mCherry and the merged image in *N. benthamiana* leaf epidermal cells. (**E**) Schematic representation of AtFH2 and the truncated proteins used for the intracellular localization analysis. SP, signal peptide; TMD, trans-membrane domain. (**F**) AtFH2^N437^-eGFP, CMV MP-mCherry and the merged image in epidermal cells of *N. benthamiana* leaves. (**G**) AtFH2^N282^-eGFP, CMV MP-mCherry and the merged image in epidermal cells of *N. benthamiana* leaves. (**H**) AtFH2^N175^-eGFP, CMV MP-mCherry and the merged image in epidermal cells of *N. benthamiana* leaves. (**I**) AtFH2^N282^-ΔTMD-eGFP, CMV MP-mCherry and the merged image in epidermal cells of *N. benthamiana* leaves. Bars = 10 μm in all images, and bars = 5 μm in all inset images.](elife-36316-fig1){#fig1}

Next, we asked how AtFH2 targets to PD. We initially found that the localization pattern of AtFH2 does not depend on the presence of an intact actin cytoskeleton ([Figure 1---figure supplement 2C,D](#fig1s2){ref-type="fig"}). This suggests that the PD localization pattern of AtFH2 is not controlled by the C-terminal FH1 and FH2 domains, which together occupy most of the AtFH2 protein and mediate its interaction with the actin cytoskeleton. We speculated that the PD localization pattern of AtFH2 might be solely determined by its TM domain, which is located near the N-terminus. To quickly test this hypothesis, we adopted the strategy of exogenous expression in tobacco leaves. The feasibility of using this strategy was demonstrated by showing that full-length AtFH2 targets to PD in tobacco leaf epidermal cells ([Figure 1D](#fig1){ref-type="fig"}). We generated several fusion constructs in which eGFP was fused with truncated fragments of AtFH2, starting from the N-terminus ([Figure 1E](#fig1){ref-type="fig"}). We subsequently demonstrated that eGFP fusion proteins of truncated AtFH2 localize to PD as long as they contain the TM domain ([Figure 1F--H](#fig1){ref-type="fig"}). The eGFP fusion protein without the TM domain failed to target to PD ([Figure 1I](#fig1){ref-type="fig"}). Thus, the data suggest that PD-localization of AtFH2 is determined by its TM domain.

The size exclusion limit (SEL) of PD is increased in *atfh2* {#s2-3}
------------------------------------------------------------

To determine whether cell-to-cell trafficking was altered in *atfh2*, we performed an eGFP diffusion assay as reported previously ([@bib34]; [@bib36]). Leaf epidermal cells were transformed by DNA bombardment with an eGFP-expressing construct. After bombardment by plasmids expressing non-mobile HDEL-mCherry along with plasmids expressing eGFP, the HDEL-mCherry signal mainly appeared in one cell ([Figure 2---figure supplement 1A](#fig2s1){ref-type="fig"}), which suggests that the eGFP signal outside this cell results from diffusion rather than local expression. The efficiency of eGFP diffusion from bombarded cells into surrounding epidermal layers was assessed by counting the number of cell layers with a diffuse eGFP signal ([Figure 2A](#fig2){ref-type="fig"}). Our results showed that eGFP diffusion across cells is significantly higher in *atfh2* than in WT ([Figure 2B](#fig2){ref-type="fig"}; [Figure 2---figure supplement 1B](#fig2s1){ref-type="fig"}). The eGFP diffusion phenotype in *atfh2* is rescued by transforming *AtFH2p:AtFH2-eGFP* into *atfh2* ([Figure 2C](#fig2){ref-type="fig"}), suggesting that increased eGFP diffusion is indeed caused by loss of function of *AtFH2*. Consistent with this notion, the number of eGFP-expressing cells within a diffusion cluster is significantly higher in *atfh2* mutant plants ([Figure 2D](#fig2){ref-type="fig"}). We found that loss of function of *AtFH2* does not affect cytoplasmic streaming ([Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}), which suggests that loss of function of *AtFH2* specifically alters cell-to-cell trafficking. However, we found that overexpression of *AtFH2* does not affect the overall organization of actin filaments or cell-to-cell trafficking in leaf epidermal cells ([Figure 2---figure supplement 3](#fig2s3){ref-type="fig"}). Next, we asked whether loss of function of *AtFH2* also affects specific movement of macromolecules across cells by examining the cell-to-cell movement of an eGFP fusion of the *Cucumber mosaic virus* (CMV) protein MP (MP-eGFP). We found that the cell-to-cell movement of MP-eGFP is also increased in *atfh2* ([Figure 2E](#fig2){ref-type="fig"}). This finding also motivated us to speculate that *atfh2* plants might become more sensitive to virus infection. To test this speculation, we challenged *Arabidopsis* plants with CMV strain Fny (Fny-CMV), which is known to infect *Arabidopsis* ([@bib18]). We found that *Arabidopsis* leaves became curved and distorted after inoculation with Fny-CMV when compared to the control ([Figure 2---figure supplement 4A,B](#fig2s4){ref-type="fig"}). The growth of leaves was inhibited ([Figure 2---figure supplement 4C,D](#fig2s4){ref-type="fig"}) and the proportion of symptomatic plants increased in a time-dependent manner ([Figure 2---figure supplement 4E](#fig2s4){ref-type="fig"}). Infection with Fny-CMV was confirmed by measurements showing that the amount of CMV *MP* RNA increases in a time-dependent manner ([Figure 2---figure supplement 4F](#fig2s4){ref-type="fig"}). We next challenged *Arabidopsis* plants with Fny-CMV and found that the symptoms of infection were more severe in *atfh2* plants than in WT plants ([Figure 2F,G](#fig2){ref-type="fig"}). This was quantified by the time-dependent increase in the relative proportion of symptomatic plants ([Figure 2H](#fig2){ref-type="fig"}) and by the relative accumulation of CMV *MP* RNA ([Figure 2I](#fig2){ref-type="fig"}) in *atfh2* mutants. In addition, the growth of *Arabidopsis* leaves was inhibited more severely in *atfh2* compared to WT plants ([Figure 2J,K](#fig2){ref-type="fig"}). These data together suggest that the SEL of PD increases in *atfh2* plants.

![Loss of function of *AtFH2* increases SEL of PD.\
(**A**) Diagram of the eGFP diffusion assay in *Arabidopsis* epidermal pavement cells. The edge of the initial cell expressing eGFP, cells in the first diffusion layer and cells in the second diffusion layer are marked by red, orange and blue lines, respectively. Bar = 10 μm. (**B, C**) Quantification of the number of cell layers showing eGFP diffusion. The number of eGFP diffusion cell layers at 24 hr and 48 hr after the bombardment was counted and plotted. The experiments were repeated at least three times, and more than 30 cells expressing eGFP were counted each time. Values represent mean ± SE. ND, no statistical difference, \*\*p\<0.01 and \*p\<0.05 by Mann-Whitney U test. Given that *atfh2-1* and *atfh2-2* exhibit a similar cell-to-cell trafficking phenotype, we only used *atfh2-1* as the representative *AtFH2* loss-of-function mutant in the following studies. (**D**) Quantification of the number of cells in an eGFP diffusion cluster. The total number of cells within the cluster was counted and plotted at 24 hr after the bombardment. The experiments were repeated at least three times, and more than 30 GFP-expressing cells were counted each time. Values represent mean ± SE. ND, no statistical difference, \*\*p\<0.01 by Mann-Whitney U test. (**E**) Quantification of the number of cell layers showing cell-to-cell movement of CMV MP-eGFP. The experiments were repeated at least three times, and more than 30 CMV MP-eGFP-expressing cells were counted each time. Values represent mean ± SE. ND, no statistical difference, \*\*p\<0.01 by Mann-Whitney U test. (**F**) Symptoms of Fny-CMV infection in WT and *atfh2* mutant plants. WT *Arabidopsis* leaves start to wrinkle at day 4, whereas *atfh2* mutant leaves start to wrinkle at day 3. Wrinkles are indicated by white arrows. The edges of leaves are marked with dashed red lines. Bar = 0.5 cm. (**G**) Symptoms in wild type (top) and *atfh2* mutant (bottom) *Arabidopsis* 2 weeks after systemic infection with Fny-CMV. All leaves from *Arabidopsis* plants 14 days after inoculation with Fny-CMV are shown. Bar = 1 cm. (**H**) Quantification of the Fny-CMV infection rate of WT, *atfh2* mutant and *AtFH2p:AtFH2-eGFP;atfh2* plants. The number of symptomatic plants (with curly leaves) was counted at different days and the relative proportion of symptomatic plants was plotted. Symptoms were evident earlier in *atfh2* mutants than in WT and *AtFH2p:AtFH2-eGFP;atfh2* plants. (**I**) Determination of the relative level of CMV *MP* transcripts by qRT-PCR in the newly grown small leaves of Fny-CMV-infected WT and *atfh2* mutant plants at day 3. Relative CMV *MP* RNA accumulation represents the relative amount of virus in plants. Values represent mean ± SE, \*\*p\<0.01 by Student's *t*-test. (**J**) Quantification of *Arabidopsis* leaf length 2 weeks after infection with Fny-CMV. Mock (water treatment); CMV (Fny-CMV treatment). The growth of *atfh2* leaves is slower than that of WT leaves after infection with Fny-CMV. Values represent mean ± SE, *n* ≥ 20. (**K**) Quantification of *Arabidopsis* leaf length at days 12, 13 and 14 after inoculation with Fny-CMV. Values represent mean ± SE, *n* ≥ 20. \*\*p\<0.01 by Student's *t*-test. ND, no statistical difference.\
10.7554/eLife.36316.022Figure 2---source data 1.Quantification of eGFP diffusion plotted in [Figure 2B](#fig2){ref-type="fig"}.\
10.7554/eLife.36316.023Figure 2---source data 2.Quantification of eGFP diffusion plotted in [Figure 2C](#fig2){ref-type="fig"}.\
10.7554/eLife.36316.024Figure 2---source data 3.Quantification of eGFP diffusion plotted in [Figure 2D](#fig2){ref-type="fig"}.\
10.7554/eLife.36316.025Figure 2---source data 4.Quantification of CMV MP transporting plotted in [Figure 2E](#fig2){ref-type="fig"}.\
10.7554/eLife.36316.026Figure 2---source data 5.Quantification of Fny-CMV infection plants plotted in [Figure 2H](#fig2){ref-type="fig"}.\
10.7554/eLife.36316.027Figure 2---source data 6.Quantification of relative CMV MP RNA accumulation plotted in [Figure 2I](#fig2){ref-type="fig"}.\
10.7554/eLife.36316.028Figure 2---source data 7.Quantification of leaf length plotted in [Figure 2J](#fig2){ref-type="fig"}.\
10.7554/eLife.36316.029Figure 2---source data 8.Quantification of leaf length plotted in [Figure 2K](#fig2){ref-type="fig"}.](elife-36316-fig2){#fig2}

The functions of AtFH2 overlap with AtFH1, another PD-localized Class I formin, in regulating cell-to-cell trafficking {#s2-4}
----------------------------------------------------------------------------------------------------------------------

The cell-to-cell trafficking phenotype is quite subtle in *atfh2*. We wondered whether this is due to the functional redundancy of AtFH2 with other Class I formins ([Figure 3A](#fig3){ref-type="fig"}). To determine whether there are additional PD-localized Class I formins in *Arabidopsis*, we examined the localization of the N-terminus of all the other *Arabidopsis* Class I formins except AtFH3 (At4g15200), which is pollen-specific ([@bib62]), and AtFH7 (At1g59910), which lacks a TM domain ([@bib13]) ([Figure 3A](#fig3){ref-type="fig"}). We found that AtFH1 (At3g25500), AtFH4 (At1g24150), AtFH8 (At1g70140) and AtFH9 (At5g48360) form obvious dot-like structures along the cell membrane whereas AtFH5 (At5g54650), AtFH6 (At5g67470), AtFH10 (At3g07540) and AtFH11 (At3g05470) are distributed uniformly on the cell membrane ([Figure 3B--I](#fig3){ref-type="fig"}). To determine whether the AtFH1-, AtFH4-, AtFH8- and AtFH9-decorated dot-like structures are PD, we performed simultaneous callose staining or colocalization with AtFH2 ([Figure 3J--O](#fig3){ref-type="fig"}) and confirmed that AtFH1 and AtFH9 localize to PD ([Figure 3J,K,N and O](#fig3){ref-type="fig"}). To determine whether the localization of Class I formins to PD is conserved in plants, we examined the intracellular localization of Class I formins in monocotyledon rice. Among 11 Class I rice formins ([Figure 3---figure supplement 1A](#fig3s1){ref-type="fig"}; [@bib13]), we found that OsFH8 (Os03g0204100), OsFH11 (Os07g0545500), OsFH15 (Os09g0517600) and OsFH16 (Os02g0739100) are able to localize to PD ([Figure 3---figure supplement 1B--E](#fig3s1){ref-type="fig"}). Given that AtFH1 and AtFH2 belong to the same subclass ([Figure 3A](#fig3){ref-type="fig"}), we generated *atfh1 atfh2* double mutants ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}) to examine whether they redundantly regulate cell-to-cell trafficking via PD. We did not detect overt developmental phenotypes in *atfh1 atfh2* mutants compared to WT, *atfh1* and *atfh2* plants ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}). However, we found that *atfh1 atfh2* mutants have stronger cell-to-cell trafficking phenotypes than *atfh1* and *atfh2* single mutants ([Figure 4](#fig4){ref-type="fig"}; [Figure 2---figure supplement 1C](#fig2s1){ref-type="fig"}). This suggests that AtFH1 and AtFH2 indeed act redundantly in regulating cell-to-cell trafficking via PD. Given that the accumulation of callose was shown to be involved in the regulation of PD permeability ([@bib11]; [@bib26]; [@bib51]), we wondered whether loss of function of *AtFH1* and/or *AtFH2* might alter the actin dynamics at PD and consequently affect the accumulation of callose at PD. We therefore performed callose staining with aniline blue and found that the amount of callose accumulated at PD in *atfh1*, *atfh2* and *atfh1 atfh2* mutants was not overtly different to that in WT plants ([Figure 4---figure supplement 2](#fig4s2){ref-type="fig"}). This suggests that the alteration in cell-to-cell trafficking in *atfh1*, *atfh2* and *atfh1 atfh2* mutants is not due to an alteration in the accumulation of callose at PD.

![Determination of the intracellular localization of *Arabidopsis* Class I formins.\
(**A**) Phylogenetic analysis of Class I *Arabidopsis* formins. The phylogenetic tree was made by MEGA 4.0 based on neighbor joining analysis. Numbers on branches represent the bootstrap values. (**B--I**) Examination of the intracellular localization pattern of Class I *Arabidopsis* formins by expressing their eGFP fusion constructs in *Arabidopsis* hypocotyl cells. (**B**) AtFH1(N)-eGFP; (**C**) AtFH4(N)-eGFP; (**D**) AtFH5-eGFP; (**E**) AtFH6(N)-eGFP; (**F**) AtFH8(N)-eGFP; (**G**) AtFH9(N)-eGFP; (**H**) AtFH10(N)-eGFP; (**I**) AtFH11(N)-eGFP. White arrows indicate punctate structures. (**J**) AtFH1(N)-eGFP, callose, and the merged image in *Arabidopsis* expressing *35S:AtFH1(N)-eGFP*. (**K**) AtFH1(N)-eGFP, AtFH2-mCherry, and the merged image in *Arabidopsis* plants expressing *35S:AtFH1(N)-eGFP* and *35S:AtFH2-mCherry*. (**L**) AtFH4(N)-eGFP, callose, and the merged image in *Arabidopsis* expressing *35S:AtFH4(N)-eGFP*. (**M**) AtFH8(N)-eGFP, callose, and the merged image in *Arabidopsis* expressing *35S:AtFH8(N)-eGFP*. (**N**) AtFH9(N)-eGFP, callose, and the merged image in *Arabidopsis* expressing *35S:AtFH9(N)-eGFP*. (**O**) AtFH9(N)-eGFP, AtFH2-mCherry, and the merged image in *Arabidopsis* plants expressing *35S:AtFH9(N)-eGFP* and *AtFH2pro:AtFH2-mCherry*. White arrows in (**J**), (**K**), (**N**) and (**O**) indicate PD. Bars = 10 μm.](elife-36316-fig3){#fig3}

![AtFH1 and AtFH2 redundantly regulate PD permeability.\
(**A**) Images of eGFP diffusion in leaf epidermal pavement cells of WT, *atfh1*, *atfh2* and *atfh1 atfh2* plants. The edge of the cell that initially expressed eGFP is marked by a red line. The edge of cells within the first, second and third diffusion layers are marked by orange, blue, and pink lines, respectively. Bar = 10 μm. (**B**) Quantification of the number of eGFP diffusion layers in leaves of WT, *atfh1*, *atfh2* and *atfh1 atfh2* plants. The number of cell layers showing eGFP diffusion at 24 hr and 48 hr was measured and plotted. Values represent mean ± SE. \*p\<0.05, and \*\*p\<0.01 by Mann-Whitney U test. More than 30 cells were counted each time and the experiments were repeated at least three times. (**C**) Quantification of the number of cells in an eGFP diffusion cluster in WT, *atfh1*, *atfh2* and *atfh1 atfh2* mutant plants. The number of cells was determined at 24 hr after the bombardment. Values represent mean ± SE. \*\*p\<0.01 by Mann-Whitney U test. More than 30 cells were counted each time and the experiments were repeated at least three times. (**D**) Quantification of the number of cell layers showing cell-to-cell movement of CMV MP-eGFP in leaves of WT, *atfh1*, *atfh2* and *atfh1 atfh2* plants. The number of diffusion cell layers at 48 hr was measured and plotted. Values represent mean ± SE. \*\*p\<0.01, by Mann-Whitney U test. More than 30 cells were counted and the experiments were repeated at least three times. (**E**) Symptom of Fny-CMV infection in WT, *atfh1*, *atfh2* and *atfh1 atfh2* mutant *Arabidopsis* plants. Small leaves started to become wrinkled (indicated by white arrows) between days 3 to 7. The edges of leaves are marked with dashed red lines. Bar = 1 cm. (**F**) Images of *Arabidopsis* leaves from WT, *atfh1*, *atfh2* and *atfh1 atfh2* plants 14 days after inoculation with Fny-CMV. Bar = 1 cm. (**G**) Quantification of the relative proportion of symptomatic plants in WT, *atfh1*, *atfh2* and *atfh1 atfh2* plants after infection with Fny-CMV. The number of symptomatic plants (with curly leaves) was counted at different days and the relative proportion of symptomatic plants was plotted. (**H**) Quantification of *Arabidopsis* leaf length after Fny-CMV infection. The length of leaves was defined according to the method shown in [Figure 2---figure supplement 4C](#fig2s4){ref-type="fig"}. The average length of *Arabidopsis* leaves was traced for 2 weeks. (**I**) Quantification of *Arabidopsis* leaf length at days 12, 13 and 14 after inoculation. Values represent mean ± SE, *n* ≥ 20. \*\*p\<0.01 by Student's *t*-test. ND, no statistical difference.\
10.7554/eLife.36316.042Figure 4---source data 1.Quantification of eGFP diffusion plotted in [Figure 4B](#fig4){ref-type="fig"}.\
10.7554/eLife.36316.043Figure 4---source data 2.Quantification of eGFP diffusion plotted in [Figure 4C](#fig4){ref-type="fig"}.\
10.7554/eLife.36316.044Figure 4---source data 3.Quantification of CMV MP transporting plotted in [Figure 4D](#fig4){ref-type="fig"}.\
10.7554/eLife.36316.045Figure 4---source data 4.Quantification of Fny-CMV infection plants plotted in [Figure 4G](#fig4){ref-type="fig"}.\
10.7554/eLife.36316.046Figure 4---source data 5.Quantification of leaf length plotted in [Figure 4H](#fig4){ref-type="fig"}.\
10.7554/eLife.36316.047Figure 4---source data 6.Quantification of leaf length plotted in [Figure 4I](#fig4){ref-type="fig"}.](elife-36316-fig4){#fig4}

AtFH2 fails to nucleate actin assembly from actin or actin bound to profilin in vitro {#s2-5}
-------------------------------------------------------------------------------------

We next generated several recombinant AtFH2 proteins, with increasingly large N-terminal deletions, to determine their effect on actin dynamics in vitro ([Figure 5A,B](#fig5){ref-type="fig"}). We initially tested whether they are able to nucleate actin assembly, which is a characteristic feature of formins ([@bib7]; [@bib24]). The *bona fide* actin nucleator AtFH1 ([@bib40]), which efficiently enhances actin assembly, was used as a positive control ([Figure 5C](#fig5){ref-type="fig"}). Unexpectedly, AtFH2 recombinant proteins failed to nucleate actin assembly; instead, they slightly inhibited actin assembly ([Figure 5C](#fig5){ref-type="fig"}). This was confirmed by directly visualizing the effect of AtFH2 recombinant proteins on actin assembly by total internal reflection fluorescence microscopy (TIRFM) ([Figure 5D,E](#fig5){ref-type="fig"}). In addition, we found that recombinant AtFH2 proteins failed to nucleate actin assembly from profilin-actin complexes ([Figure 5F](#fig5){ref-type="fig"}). Thus, our results showed that AtFH2 fails to nucleate actin assembly from actin or actin bound to profilin in vitro.

![AtFH2 fails to nucleate actin assembly from actin or actin bound to profilin, and slightly inhibits spontaneous actin polymerization in vitro.\
(**A**) Schematic representation of the domain organization of AtFH2 and the fragments used for the generation of recombinant truncated AtFH2 proteins. (**B**) Purified recombinant truncated AtFH2 proteins. The recombinant AtFH2 proteins were resolved on 10% SDS-PAGE and stained with Coomassie blue. Lane 1, AtFH2-ΔN; lane 2, AtFH2-FH1FH2; lane 3, AtFH2-FH2. (**C**) The effect of AtFH2 on spontaneous actin assembly from G-actin alone. Actin (10% pyrene-labeled, 3 μM) was incubated with recombinant formin proteins (1 μM) for 5 min at room temperature before the addition of 10 × KMEI to initiate actin polymerization, and actin polymerization was traced by monitoring the changes in pyrene fluorescence. (**D**) Time-lapse images of actin filaments in the absence or presence of formin proteins. \[Actin\], 1.5 μM (33.3% Oregon Green-labeled); \[AtFH2-ΔN\], 400 nM; \[AtFH1-FH1FH2\], 100 nM. Bar = 10 μm. (**E**) Quantification of the number of actin filaments per microscope field. Values represent mean ± SE, *n* = 3. \*\*p\<0.01 by Student's *t*-test. (**F**) AtFH2 fails to utilize profilin-actin complexes. Actin (10% pyrene-labeled, 3 μM) plus human profilin I (3 μM) were incubated with recombinant formin proteins (1 μM) for 5 min at room temperature before the addition of 10 × KMEI to initiate actin polymerization, and actin polymerization was traced by monitoring the changes in pyrene fluorescence. AtFH1-FH1FH2 ([@bib40]) was used as the control in (**C**) and (**F**).\
10.7554/eLife.36316.049Figure 5---source data 1.Quantification of number of actin filaments plotted in [Figure 5E](#fig5){ref-type="fig"}.](elife-36316-fig5){#fig5}

AtFH2 caps the barbed end of actin filaments and stabilizes them from depolymerization {#s2-6}
--------------------------------------------------------------------------------------

To determine whether AtFH2 has the characteristic barbed end capping activity of formins, we performed the seeded actin elongation assay. We found that recombinant AtFH2-ΔN, AtFH2-FH1FH2 and AtFH2-FH2 prevented the addition of profilin-actin complexes in a dose-dependent manner ([Figure 6A,B](#fig6){ref-type="fig"}), suggesting that AtFH2 does indeed have barbed end capping activity. From three independent experiments, the average dissociation constant (*K*~d~) (mean ± SE, *n* = 3) was determined to be 80.3 ± 12.9 nM, 163.3 ± 22.2 nM and 354.6 ± 49.0 nM for AtFH2-ΔN, AtFH2-FH1FH2 and AtFH2-FH2, respectively. The barbed end capping activity of AtFH2 was also confirmed by showing that AtFH2 blocks the annealing of actin filaments ([Figure 6C,D](#fig6){ref-type="fig"}) and inhibits their elongation ([Figure 6E,F](#fig6){ref-type="fig"}). Similar to the features reported for other barbed end capping proteins, we found that AtFH2 protects actin filaments from dilution-mediated actin depolymerization in a dose-dependent manner ([Figure 6G](#fig6){ref-type="fig"}). Thus, our results demonstrated that AtFH2 caps the barbed end of actin filaments and stabilizes them in vitro.

![AtFH2 caps the barbed end of actin filaments and stabilizes them from dilution-mediated actin depolymerization.\
(**A**) AtFH2-ΔN inhibits actin barbed end elongation in a dose-dependent manner. Pre-formed F-actin seeds (0.8 μM) were incubated with different concentrations of AtFH2-ΔN for 5 min at room temperature, and 1 μM G-actin (10% pyrene-labeled) saturated with 4 μM human profilin I was subsequently added to initiate actin elongation at the barbed end. (**B**) Determination of the dissociation constant (*K*~d~) for the interaction between AtFH2 recombinant proteins and the barbed end of actin filaments. The initial rates of elongation were plotted versus the concentration of recombinant formin proteins (AtFH2-ΔN, AtFH2-FH1FH2 and AtFH2-FH2). The *K*~d~ values were calculated to be 80 nM, 183 nM and 329 nM for AtFH2-ΔN, AtFH2-FH1FH2 and AtFH2-FH2, respectively. (**C**) Micrographs of actin filaments before and after annealing. Preassembled actin filaments (4 μM) labeled with equimolar rhodamine-phalloidin were sheared with needles in the absence or presence of AtFH2-ΔN (2 μM). Bar = 10 μm. (**D**) Quantification of the length of actin filaments before and after annealing. The average length of actin filaments at 0 min, 30 min and 60 min was plotted; values represent mean ± SE, *n* ≥ 100. \*\*p\<0.01 by Student's *t*-test. ND, no statistical difference. (**E**) Time-lapse images of actin filaments in the absence or presence of recombinant formin proteins (left panel). White arrows indicate the elongating end of actin filaments. The right panels are the kymograph analyses of growing actin filaments shown in the left panels. \[Actin\], 1.5 μM (33.3% Oregon Green-labeled); \[AtFH2-ΔN\], 400 nM; \[AtFH1-FH1FH2\], 400 nM. Bars = 10 μm. (**F**) Quantification of the elongation rates of actin filaments in the absence or presence of recombinant formin proteins. The average elongation rates (mean ± SE, *n* ≥ 20; subunits/s) of actin filaments are 11.34 ± 0.24, 4.36 ± 0.16 and 3.1 ± 0.06 for actin alone, actin +400 nM AtFH2-ΔN and actin +800 nM AtFH2-ΔN, respectively. (**G**) Plot of dilution-induced actin depolymerization curves. Various concentrations of AtFH2-ΔN were incubated with preformed actin filaments (5 μM, 50% pyrene-labelled) for 5 min at room temperature before being diluted 25-fold into Buffer G.\
10.7554/eLife.36316.051Figure 6---source data 1.Quantification of of the dissociation constant (Kd) of AtFH2 plotted in [Figure 6B](#fig6){ref-type="fig"}.\
10.7554/eLife.36316.052Figure 6---source data 2.Quantification of the length of actin filaments plotted in [Figure 6D](#fig6){ref-type="fig"}.\
10.7554/eLife.36316.053Figure 6---source data 3.Quantification of the elongation rates of actin filaments plotted in [Figure 6F](#fig6){ref-type="fig"}.](elife-36316-fig6){#fig6}

Interaction between AtFH2 and actin filaments is crucial for the function of AtFH2 in regulating cell-to-cell trafficking in *Arabidopsis* {#s2-7}
------------------------------------------------------------------------------------------------------------------------------------------

To directly examine whether the involvement of AtFH2 in the regulation of cell-to-cell trafficking is via its interaction with the actin cytoskeleton, we genetically manipulated AtFH2 in order to alter its interaction with actin filaments. It was reported that substitution of Ile1431 with alanine (A) or of Lys1601 with aspartic acid (D) within the FH2 domain of the yeast formin Bni1p completely abolished the actin binding activity of its FH2 domain since it fails to form dimers ([@bib59]). We therefore mutated the corresponding residues in AtFH2 in order to inhibit its dimer formation and disrupt its interaction with actin filaments. We found that two residues, Ile519 and Lys672, in AtFH2 correspond to the conserved Ile1431 and Lys1601 in Bni1p ([Figure 7A](#fig7){ref-type="fig"}). We initially replaced Ile519 with A and Lys672 with D in AtFH2-FH2 and generated the recombinant AtFH2-FH2^I519A,K672D^ protein ([Figure 7B](#fig7){ref-type="fig"}; named as AtFH2-FH2M hereafter). We found that, unlike AtFH2-FH2, AtFH2-FH2M failed to inhibit actin nucleation ([Figure 7C](#fig7){ref-type="fig"}) and actin filament elongation ([Figure 7D](#fig7){ref-type="fig"}). In contrast to AtFH2-FH2, which is mainly in the dimeric form, AtFH2-FH2M is mainly in the monomeric form ([Figure 7E](#fig7){ref-type="fig"}). These data together suggest that AtFH2-FH2M fails to dimerize and interact with actin filaments. To determine how the mutation affects the role of AtFH2 in regulating PD-mediated cell-to-cell trafficking, we initially found that AtFH2M-eGFP still localizes to PD ([Figure 7F](#fig7){ref-type="fig"}). In contrast to AtFH2-eGFP, we found that AtFH2M failed to rescue the cell-to-cell trafficking phenotype in *atfh2* mutants assayed with eGFP diffusion ([Figure 7G](#fig7){ref-type="fig"}) and virus infection ([Figure 7H](#fig7){ref-type="fig"}) experiments. Thus, these data together suggest that the regulatory function of AtFH2 on PD permeability depends on its interaction with the actin cytoskeleton.

![Interaction of AtFH2 with actin filaments is required for its function in regulating the permeability of PD.\
(**A**) Protein sequence alignment of the FH2 domains in AtFH2 and three other well-characterized formins. Ile519 (**I**) and Lys672 (**K**) in AtFH2 (red triangles) correspond to Ile1431 and Lys1601 in Bni1p. These residues were previously shown to be important for the dimer formation and actin nucleation activity of Bni1p ([@bib59]). *S. cerevisiae* Bni1p (Bni1), P41832; human diaphanous protein 1 (Dia1), O60610; AtFH1, Q9SE97. (**B**) SDS-PAGE analysis of recombinant AtFH2-FH2 and AtFH2-FH2M. Lane 1, GST-AtFH2-FH2; lane 2, GST-AtFH2-FH2M. (**C**) The effect of AtFH2-FH2 and AtFH2-FH2M on spontaneous actin assembly. The conditions for actin assembly are described in [Figure 5C](#fig5){ref-type="fig"}. (**D**) The effect of AtFH2-FH2 and AtFH2-FH2M on seeded actin elongation. The conditions for actin assembly are described in [Figure 6A](#fig6){ref-type="fig"}. (**E**) Elution volume of AtFH2-FH2 (red line) and AtFH2-FH2M (blue line) by size exclusion chromatography. To exclude the potential interference of GST in dimer formation, His-tag fusion proteins were generated. The inset shows SDS-PAGE analysis of 6His-AtFH2-FH2 and 6His-AtFH2-FH2M. The estimated molecular weight is about 100 kDa for AtFH2-FH2 and 50 kDa for AtFH2-FH2M. (**F**) Subcellular localization of AtFH2M-eGFP and CMV MP-mCherry in epidermal pavement cells of *N. benthamiana* leaves. Bar = 10 μm. (**G**) Quantification of eGFP diffusion cell layers in *Arabidopsis* leaf epidermal cells. AtFH2M represents *AtFH2p:AtFH2M;atfh2*, and AtFH2-eGFP represents *AtFH2p:AtFH2-eGFP;atfh2*. The number of diffusion cell layers at 24 hr and 48 hr was plotted. Error bars represent SE, *n* \> 30, \*\*p\<0.01 by Mann-Whitney U test. ND, no statistical difference. The experiment was repeated at least three times. (**H**) Quantification of Fny-CMV infection rates in *Arabidopsis* plants. The number of symptomatic plants (with curly leaves) was counted at different days and the relative proportion of symptomatic plants was plotted.\
10.7554/eLife.36316.055Figure 7---source data 1.Quantification of eGFP diffusion plotted in [Figure 7G](#fig7){ref-type="fig"}.\
10.7554/eLife.36316.056Figure 7---source data 2.Quantification of Fny-CMV infection plants plotted in [Figure 7H](#fig7){ref-type="fig"}.](elife-36316-fig7){#fig7}

Discussion {#s3}
==========

Here, we demonstrate that the Class I formin AtFH2 localizes to PD through its TM domain and is involved in the regulation of cell-to-cell trafficking via PD. Given that AtFH2 is a simple actin filament barbed end capper that stabilizes actin filaments in vitro ([Figures 5](#fig5){ref-type="fig"} and [6](#fig6){ref-type="fig"}), we propose that AtFH2 acts as an anchor that tethers actin filaments to the membrane at PD and stabilizes the filaments through its barbed end capping activity. In the absence of AtFH2, the amount of actin filaments is assumed to be reduced at PD. In this regard, our findings that loss of function of *AtFH2* increases the SEL of PD ([Figures 2](#fig2){ref-type="fig"} and [4](#fig4){ref-type="fig"}) are consistent with previous results, obtained from actin-based pharmacological treatments, showing that destabilization of actin filaments increases the SEL of PD ([@bib17]; [@bib53]). These data together allow us to conclude that the stability and/or the amount of actin filaments is crucial for their role in regulating the permeability of PD. Our study thus significantly enhances our understanding of actin-mediated regulation of intercellular trafficking via PD in plants.

Decades of studies have confirmed the presence of the actin cytoskeletal system at PD and demonstrated its involvement in the regulation of PD-mediated intercellular trafficking ([@bib17]; [@bib22]; [@bib53]), but the underlying molecular and cellular mechanisms remain largely unknown. Studies in this area have progressed slowly for at least two reasons. First, we still lack approaches to specifically visualize actin at PD since they are small and buried deeply in the cell wall. Consequently, the existence of filamentous forms of actin at PD remains controversial. Second, we still lack approaches to specifically perturb actin dynamics at PD. Identification of the native components of the actin cytoskeletal system that specifically localize to PD may provide targets for the genetic manipulation of the actin cytoskeleton in this region, which will enhance our understanding of how actin at PD regulates cell-to-cell trafficking.

Identification of the localization of AtFH2 to PD and demonstration of its involvement in PD permeability open a window for us to dissect the status, organization and functions of actin at PD. Several lines of evidence show that loss of function of *AtFH2* increases the SEL of PD ([Figures 2](#fig2){ref-type="fig"} and [4](#fig4){ref-type="fig"}; [Figure 2---figure supplement 1B,C](#fig2s1){ref-type="fig"}). Although we cannot directly visualize the organization of actin at PD in WT or *atfh2* plants, we speculate that the amount of F-actin is reduced at PD in *atfh2* plants since AtFH2 caps and stabilizes actin filaments even though it lacks the characteristic actin nucleation activity ([Figures 5](#fig5){ref-type="fig"} and [6](#fig6){ref-type="fig"}). Our data allow us to propose that PD-localized AtFH2 recruits actin filaments to PD by capping the barbed end of actin filaments and stabilizing them, which consequently regulates cell-to-cell trafficking. Given that AtFH2 is a simple actin barbed end capper that stabilizes actin filaments in vitro ([Figures 5](#fig5){ref-type="fig"} and [6](#fig6){ref-type="fig"}) and loss of function of *AtFH2* increases the permeability of PD ([Figures 2](#fig2){ref-type="fig"} and [4](#fig4){ref-type="fig"}), it is likely that there are fewer actin filaments at PD in *atfh2* mutants, so that intercellular trafficking is upregulated. Our results, along with previous data from actin-based pharmacological treatments showing that destabilization of actin filaments increases SEL of PD ([@bib17]; [@bib53]), suggest that actin filaments at PD may act as the physical barrier to regulate its permeability ([@bib6]). To gain further insights into the function of actin filaments in the regulation of the permeability of PD, it will be necessary in the future to determine where AtFH2-tethered actin filaments localize along the transport path of PD. The reconstructed three-dimensional ultrastructure of post-cytokinesis plasmodesmata using electron tomography showed that the gap between the plasma membrane (PM) and the ER (called the cytoplasmic sleeve) within plasmodesmata pores is less than 10 nm ([@bib42]). This suggests that there is unlikely to be enough space to fit more actin filaments within the cytoplasmic sleeve of PD. The authors also discovered a second PD morphotype (type I) that lacks a visible cytoplasmic sleeve but is capable of non-targeted movement of macromolecules ([@bib42]), which urges us to rethink the relationship between the size of the cytoplasmic sleeve and the permeability. Nonetheless, these findings suggest that the contact between ER and PM is very dynamic. In this regard, AtFH2-tethered actin filaments might be involved in the regulation of the dynamic connection between ER and PM, and may consequently modulate the permeability of PD, although the underlying mechanism remains largely unknown at the moment. Certainly, it might also be possible that AtFH2-tethered actin filaments localize at the neck region of PD to regulate cell-to-cell transportation. Again, it remains to be established how AtFH2-tethered actin filaments at the neck of PD act as a barrier in cell-to-cell trafficking.

It is intriguing that loss of function of both *AtFH1* and *AtFH2* does not have an overt effect on *Arabidopsis* growth and development ([Figure 4---figure supplement 1H,I](#fig4s1){ref-type="fig"}), even though it significantly increases the permeability of PD ([Figure 4A--D](#fig4){ref-type="fig"}). The biological significance of formin-mediated regulation of PD permeability is supported by the finding that loss of function of *AtFH1* and/or *AtFH2* increases the sensitivity of *Arabidopsis* plants to infection by Fny-CMV ([Figure 4E--I](#fig4){ref-type="fig"}). This suggests that the processes involved in normal plant development may be less sensitive to changes in formin-mediated regulation of PD permeability than the processes involved in coping with biotic stress. Given that AtFH2 is a simple actin barbed end capper ([Figures 5](#fig5){ref-type="fig"} and [6](#fig6){ref-type="fig"}), it is still an outstanding question how the barbed end capping activity of AtFH2 is tightly regulated in response to developmental and environmental cues in order to fine-tune the permeability of PD.

Surprisingly, and unlike previously characterized formins ([@bib5]; [@bib7]; [@bib24]; [@bib31]), AtFH2 lacks actin nucleation activity in the presence or absence of profilin but retains the actin filament barbed end capping activity in vitro ([Figures 5](#fig5){ref-type="fig"} and [6](#fig6){ref-type="fig"}). The crystal structure of the FH2 domain derived from yeast Bni1p showed that it forms a stable yet flexible dimer ([@bib59]). The later co-crystal of Bni1p FH2 in complex with actin demonstrates the flexibility of the FH2 dimer, which permits the addition of actin monomers onto the barbed end of actin filaments ([@bib44]). Based on the structural and biochemical data, it was proposed that the FH2 dimer exists in a dynamic equilibrium between a 'closed' and an 'open' state ([@bib31]). It is possible that FH2 dimers in AtFH2 might be less flexible, and are able to cap the barbed end of actin filaments but cannot facilitate the further addition of actin or actin-profilin complexes. In the future, careful examination of the molecular details underlying the unique activity of AtFH2 may provide insights into the mechanism of action of formin in regulating actin nucleation and elongation. Nonetheless, based on the unique biochemical properties of AtFH2, we propose that it serves well as an anchor for tethering actin filaments at the membrane of PD by capping the barbed end of actin filaments. Since AtFH2 presumably only interacts with filamentous actin through its barbed end capping activity ([Figures 5](#fig5){ref-type="fig"} and [6](#fig6){ref-type="fig"}), and the interaction of AtFH2 with actin filaments was demonstrated to be crucial for its in vivo functions ([Figure 7G,H](#fig7){ref-type="fig"}), this study to some extent provides another piece of evidence supporting the presence of filamentous actin at PD.

Interestingly, we found that AtFH1, the closest homolog of AtFH2, is also able to target to PD ([Figure 3](#fig3){ref-type="fig"}) and functions redundantly with AtFH2 in the regulation of intercellular trafficking ([Figure 4](#fig4){ref-type="fig"}). Biochemically, their functional redundancy is likely due to the fact that both have capping activity ([Figure 6](#fig6){ref-type="fig"}; \[[@bib40]\]). Considering that AtFH1 is a non-processive actin nucleation factor ([@bib41]), AtFH1 and AtFH2 might coordinately regulate actin dynamics at PD, with AtFH1 promoting actin polymerization to generate more actin filaments around PD, and AtFH2 subsequently taking over the binding to the barbed end of actin filaments after the dissociation of AtFH1. We cannot completely rule out the possibility that AtFH2 might have actin nucleation activity when bound to other proteins and/or after post-translational modification in vivo. More work needs to be undertaken to examine these possibilities in the future. Nonetheless, our findings provide insights into the functional specification of members of the formin protein family and the functional adaptation of the actin cytoskeletal system in plants in general.

Our results showed that the localization of AtFH2 is determined by its TM domain ([Figure 1](#fig1){ref-type="fig"}), which suggests that the TM domain of AtFH2 has evolved to allow it to adapt to regulate actin dynamics at PD. Given that the membrane of PD has a unique phospholipid composition ([@bib25]), the TM domains of AtFH1 and AtFH2 may bind preferentially to certain phospholipid(s) when compared to other Class I formins in *Arabidopsis*. Strikingly, we showed that several rice Class I formins localize to PD ([Figure 3---figure supplement 1B--E](#fig3s1){ref-type="fig"}), suggesting that the involvement of Class I formins in regulating actin dynamics at PD might be evolutionarily conserved in plants.

In summary, we found that AtFH2 localizes to PD and functions redundantly with AtFH1 to regulate cell-to-cell trafficking in *Arabidopsis*. Based on the in vitro biochemical data that AtFH2 caps and stabilizes actin filaments, we propose that AtFH2 regulates cell-to-cell trafficking by tethering actin filaments to the membrane at PD and stabilizing them through its barbed end capping activity. Our study suggests that the stability and/or the amount of actin filaments at PD is crucial for the permeability of PD.

Materials and methods {#s4}
=====================

  -------------------------------------------------------------------------------------------------------------------------------------------------
  Reagent type\              Designation                  Source or reference            Identifiers            Additional information
  (species) or resource                                                                                         
  -------------------------- ---------------------------- ------------------------------ ---------------------- -----------------------------------
  Gene\                      *AtFH1*                      PMID: 14671023                 TAIR: At3g25500        
  (*Arabidopsis thaliana*)                                                                                      

  Gene\                      *AtFH2*                      this paper                     TAIR: At2g43800        
  (*Arabidopsis thaliana*)                                                                                      

  Gene\                      *AtFH4*                      PMID: 16313636                 TAIR: At1g24150        
  (*Arabidopsis thaliana*)                                                                                      

  Gene\                      *AtFH5*                      PMID: 15765105                 TAIR: At5g54650        
  (*Arabidopsis thaliana*)                                                                                      

  Gene\                      *AtFH6*                      PMID: 15319477                 TAIR: At5g67470        
  (*Arabidopsis thaliana*)                                                                                      

  Gene\                      *AtFH8*                      PMID: 16313636                 TAIR: At1g70140        
  (*Arabidopsis thaliana*)                                                                                      

  Gene\                      *AtFH9*                      NA                             TAIR: At5g48360        
  (*Arabidopsis thaliana*)                                                                                      

  Gene\                      *AtFH10*                     NA                             TAIR: At3g07540        
  (*Arabidopsis thaliana*)                                                                                      

  Gene\                      *AtFH11*                     NA                             TAIR: At3g05470        
  (*Arabidopsis thaliana*)                                                                                      

  Gene\                      *OsFH8*                      PMID: 15256004                 RAP-DB: Os03g0204100   
  (*Oryza sativa*)                                                                                              

  Gene\                      *OsFH11*                     PMID: 15256004                 RAP-DB: Os07g0545500   
  (*Oryza sativa*)                                                                                              

  Gene\                      *OsFH15*                     PMID: 15256004                 RAP-DB: Os09g0517600   
  (*Oryza sativa*)                                                                                              

  Gene\                      *OsFH16*                     PMID: 15256004                 RAP-DB: Os02g0739100   
  (*Oryza sativa*)                                                                                              

  Genetic reagent\           *atfh2-1*                    this paper                     GK_066D02              
  (*Arabidopsis thaliana*)                                                                                      

  Genetic reagent\           *atfh2-2*                    this paper                     GK_396H03              
  (*Arabidopsis thaliana*)                                                                                      

  Genetic reagent\           *atfh1-1*                    PMID: 23202131                 Salk_032981            
  (*Arabidopsis thaliana*)                                                                                      

  Genetic reagent\           *atfh1-3*                    this paper                     Salk_143939            
  (*Arabidopsis thaliana*)                                                                                      

  Strain, strain\            DH5α                         PMID: 6345791                                         
  background\                                                                                                   
  (*Escherichia coli*)                                                                                          

  Strain, strain\            GV3101                       other                                                 widely distributed
  background\                                                                                                   
  (*Agrobacterium*\                                                                                             
  *tumefaciens*)                                                                                                

  Strain, strain\            Tuner (DE3)\                 other                                                 Novagen, Schwalbach,\
  background\                (pLysS)                                                                            Germany
  (*Escherichia coli*)                                                                                          

  Transfected\               pdGN (vector)                PMID: 16126836                                        
  construct                                                                                                     

  Transfected\               *pdGN-35S:HDEL-*\            this paper                                            vector-promoter:\
  construct                  *mCherry*                                                                          protein construct

  Transfected\               pCambia1301 (vector)         other                          GenBank: AF234297.1    binary vector
  construct                                                                                                     

  Transfected\               pBI101 (vector)              other                          GenBank: U12639.1      binary vector
  construct                                                                                                     

  Biological\                *PDLP1pro:PDLP1-*\           PMID: 18215111                                        
  sample\                    *GFP*                                                                              
  (*Arabidopsis thaliana*)                                                                                      

  Biological\                *PDCB1pro:YFP-*\             PMID: 19223515                                        
  sample\                    *PDCB1*                                                                            
  (*Arabidopsis thaliana*)                                                                                      

  Biological\                *AFH2p:AFH2-*\               this paper                                            promoter:eGFP fusion\
  sample\                    *eGFP; atfh2*                                                                      protein; *atfh2-1* mutant\
  (*Arabidopsis thaliana*)                                                                                      background

  Biological\                *AFH2p:AFH2-*\               this paper                                            promoter:eGFP fusion\
  sample\                    *mCherry; atfh2*                                                                   protein; *atfh2-1* mutant\
  (*Arabidopsis thaliana*)                                                                                      background

  Biological\                *35S:AFH2-*\                 this paper                                            promoter:eGFP fusion\
  sample\                    *mCherry; Col-0*                                                                   protein; Col-0\
  (*Arabidopsis thaliana*)                                                                                      background

  Biological\                *35S:AtFH1(N)-*\             this paper                                            promoter:eGFP fusion\
  sample\                    *eGFP; Col-0*                                                                      protein; Col-0\
  (*Arabidopsis thaliana*)                                                                                      background

  Biological\                *35S:AtFH4(N)-*\             this paper                                            promoter:eGFP fusion\
  sample\                    *eGFP; Col-0*                                                                      protein; Col-0 background
  (*Arabidopsis thaliana*)                                                                                      

  Biological\                *35S:AtFH5-eGFP;*\           this paper                                            promoter:eGFP fusion\
  sample\                    *Col-0*                                                                            protein; Col-0 background
  (*Arabidopsis thaliana*)                                                                                      

  Biological\                *35S:AtFH6(N)-*\             this paper                                            promoter:eGFP fusion\
  sample\                    *eGFP; Col-0*                                                                      protein; Col-0 background
  (*Arabidopsis thaliana*)                                                                                      

  Biological\                *35S:AtFH8(N)-*\             this paper                                            promoter:eGFP fusion\
  sample\                    *eGFP; Col-0*                                                                      protein; Col-0 background
  (*Arabidopsis thaliana*)                                                                                      

  Biological\                *35S:AtFH9(N)-*\             this paper                                            promoter:eGFP fusion\
  sample\                    *eGFP; Col-0*                                                                      protein; Col-0 background
  (*Arabidopsis thaliana*)                                                                                      

  Biological\                *35S:AtFH10(N)-*\            this paper                                            promoter:eGFP fusion\
  sample\                    *eGFP; Col-0*                                                                      protein; Col-0 background
  (*Arabidopsis thaliana*)                                                                                      

  Biological\                *35S:AtFH11(N)-*\            this paper                                            promoter:eGFP fusion\
  sample\                    *eGFP; Col-0*                                                                      protein; Col-0 background
  (*Arabidopsis thaliana*)                                                                                      

  Biological\                *35S:GFP-ABD2;*\             PMID: 15557099                                        promoter:eGFP fusion\
  sample\                    *Col-0*                                                                            protein; Col-0 background
  (*Arabidopsis thaliana*)                                                                                      

  Biological\                *AFH2p:AFH2M;*\              this paper                                            promoter:recombinant\
  sample\                    *atfh2*                                                                            protein; *atfh2-1* background
  (*Arabidopsis thaliana*)                                                                                      

  Recombinant\               *pGD-CMV*\                   PMID: 20435906                                        
  DNA reagent                *MP-mCherry*                                                                       

  Recombinant\               *pBI101-35S:AtFH2^N175^-*\   this paper                                            vector-promoter:protein\
  DNA reagent                *eGFP-NOS*                                                                         construct

  Recombinant\               *pBI101-*\                   this paper                                            vector-promoter:protein\
  DNA reagent                *35S:AtFH2^N282^-*\                                                                construct
                             *eGFP-NOS*                                                                         

  Recombinant\               *pBI101-35S:*\               this paper                                            vector-promoter:protein\
  DNA reagent                *AtFH2^N437^-eGFP-*\                                                               construct
                             *NOS*                                                                              

  Recombinant\               *pBI101-35S:*\               this paper                                            vector-promoter:protein\
  DNA reagent                *AtFH2^N282^-TMD-*\                                                                construct
                             *eGFP-NOS*                                                                         

  Recombinant\               *pBI101-35S:*\               this paper                                            vector-promoter:protein construct
  DNA reagent                *OsFH8(N)-eGFP-*\                                                                  
                             *NOS*                                                                              

  Recombinant\               *pBI101-35S:*\               this paper                                            vector-promoter:protein construct
  DNA reagent                *OsFH11(N)-eGFP-*\                                                                 
                             *NOS*                                                                              

  Recombinant\               *pBI101-35S:*\               this paper                                            vector-promoter:protein construct
  DNA reagent                *OsFH15(N)-eGFP-*\                                                                 
                             *NOS*                                                                              

  Recombinant\               *pBI101-35S:*\               this paper                                            vector-promoter:protein construct
  DNA reagent                *OsFH16(N)-eGFP-*\                                                                 
                             *NOS*                                                                              

  Recombinant\               *pCambia1301-35S:*\          this paper                                            vector-promoter:protein construct
  DNA reagent                *AtFH2M-eGFP-*\                                                                    
                             *NOS*                                                                              

  Recombinant\               AtFH1-FH1FH2                 PMID: 15994911                 Q9SE97                 
  protein                                                                                                       

  Recombinant\               6His-AtFH2-ΔN                this paper                                            
  protein                                                                                                       

  Recombinant\               6His-AtFH2-FH1FH2            this paper                                            
  protein                                                                                                       

  Recombinant\               6His-AtFH2-FH2               this paper                                            
  protein                                                                                                       

  Recombinant\               6His-AtFH2-FH2M              this paper                                            
  protein                                                                                                       

  Recombinant\               GST-AtFH2-FH2                this paper                                            
  protein                                                                                                       

  Recombinant\               GST-AtFH2-FH2M               this paper                                            
  protein                                                                                                       

  Chemical\                  latrunculin B                Calbiochem                     428020                 
  compound, drug                                                                                                

  Software,\                 ImageJ                       <https://imagej.nih.gov/ij/>                          version 1.51
  algorithm                                                                                                     

  Software,\                 IBM SPSS Statistics          other                                                 version 25
  algorithm                                                                                                     
  -------------------------------------------------------------------------------------------------------------------------------------------------

Plant materials and growth conditions {#s4-1}
-------------------------------------

T-DNA insertion lines GK_066D02, GK_396H03, Salk_032981 and Salk_143939 were designated as *atfh2-1*, *atfh2-2*, *atfh1-1* and *atfh1-3*, respectively. Information about the mutant *atfh1-1* has been presented previously ([@bib48]). Double mutant *atfh1 atfh2* was generated by crossing *atfh2-1* with *atfh1-3*, and *atfh1-3 atfh2-1* is named as *atfh1 atfh2* throughout the manuscript. *Arabidopsis* Columbia-0 (Col-0) ecotype was used as wild-type (WT) and *Arabidopsis* plants were grown in soil or media under a 16-h-light/8-h-dark photoperiod at 22°C. *Nicotiana benthamiana* plants were grown in pots placed in growth-rooms at 25°C under a 16-h-light/8-h-dark cycle.

Identification of T-DNA insertion mutants of *AtFH1* and *AtFH2* {#s4-2}
----------------------------------------------------------------

The genotyping of *atfh2-1* and *atfh2-2* was performed with primer pairs *atfh2-1* LP/*atfh2-1* RP and *atfh2-2* LP/*atfh2-2* RP ([Supplementary File 1](#supp1){ref-type="supplementary-material"}) in combination with left border primer GK_LB ([Supplementary File 1](#supp1){ref-type="supplementary-material"}), and the genotyping of *atfh1-1* and *atfh1-3* was performed with primer pairs *atfh1-1* LP/*atfh1-1* RP and *atfh1-3* LP/*atfh1-3* RP ([Supplementary File 1](#supp1){ref-type="supplementary-material"}) in combination with left border primer Salk_LB ([Supplementary File 1](#supp1){ref-type="supplementary-material"}), respectively. RT-PCR was performed to determine the transcript levels of *AtFH1* and *AtFH2* in their loss-of-function mutants. Total RNA was isolated from leaves of 4-week-old plants using Trizol reagent (Invitrogen) and reverse transcribed using MMLV reverse transcriptase (Promega) according to the manufacturer's instructions. To perform semi-quantitative RT-PCR analysis, two primer pairs *AtFH2*~CDSFOR~/*AtFH2*~CDSREV~ and *AtFH1*~CDSFOR~/*AtFH1*~CDSREV~ ([Supplementary File 1](#supp1){ref-type="supplementary-material"}) were used to amplify full-length *AtFH2* and *AtFH1* from WT and their loss-of-function mutants. To perform quantitative RT-PCR analysis, two primer pairs Q1/Q2 and Q3/Q4 ([Supplementary File 1](#supp1){ref-type="supplementary-material"}) were used to determine the transcript levels of *AtFH2* and *AtFH1*, respectively. *eIF4A* was used as an internal control and was ampliﬁed with primers *eIF4A*~FOR~/*eIF4A*~REV~ ([Supplementary File 1](#supp1){ref-type="supplementary-material"}). The 2^−ΔΔCt^ method was used to quantify the qRT-PCR results. 2 × RealStar Power SYBR Mixture (GeneStar) was used for the amplification.

Plasmid construction {#s4-3}
--------------------

AtFH2-eGFP fusion constructs, driven either by the *AtFH2* promoter or the *35S* promoter were generated to determine the subcellular localization of AtFH2. The promoter of *AtFH2* was amplified with *AtFH2*~PROFOR~ and *AtFH2*~PROREV~ primers ([Supplementary File 1](#supp1){ref-type="supplementary-material"}) using *Arabidopsis* genomic DNA as the template, and the coding sequence (CDS) of *AtFH2* was amplified from WT *Arabidopsis* cDNA using *AtFH2*~CDSFOR~ and *AtFH2*~CDSREV~ primers ([Supplementary File 1](#supp1){ref-type="supplementary-material"}). The promoter and CDS were cloned into *pEASY-Blunt* vector (TransGen). The CDS of *AtFH2* was subsequently moved into *pCAMBIA1301-35S:eGFP-NOS* or *pCAMBIA1301-35S:mCherry-NOS* to generate *pCAMBIA1301-35S:AtFH2-eGFP-NOS* or *pCAMBIA1301-35S:AtFH2-mCherry-NOS* plasmids, or moved into *pCAMBIA1301-eGFP-NOS* or *pCAMBIA1301-mCherry-NOS* along with the promoter of *AtFH2* to generate *pCAMBIA1301-AtFH2p:AtFH2-eGFP-NOS* or *pCAMBIA1301-AtFH2p:AtFH2-mCherry-NOS* plasmids. Substitution of isoleucine-519 with alanine (I519A) and lysine-672 with aspartic acid (K672D) was achieved by changing AT to GC and AAA to GAT by PCR with primers containing the corresponding nucleotide changes (M1/M2 and M3/M4; see [Supplementary File 1](#supp1){ref-type="supplementary-material"}) using *pEASY-Blunt-AtFH2* plasmid as the template. The resulting *pEASY-Blunt-AtFH2M* plasmid was digested with *Sal*I/*BamH*I and the resulting *AtFH2M* fragment was moved into *pCAMBIA1301-35S:eGFP-NOS or pCAMBIA1301-NOS* along with the promoter of *AtFH2* to generate *pCAMBIA1301-35S:AtFH2M-eGFP-NOS* and *pCAMBIA1301-AtFH2p:AtFH2M-NOS*. Those plasmids were introduced into *Agrobacterium tumefaciens* strain GV3101 and transformed into either WT or *atfh2* plants via the floral dip method ([@bib10]). The T3 homozygous plants were used for subsequent analyses.

To determine whether PD localization of AtFH2 is determined by its N-terminus, three N-terminal fragments, designated as AtFH2^N437^, AtFH2^N282^ and AtFH2^N175^, were amplified with primer pairs, *AtFH2*~CDSFOR~/*AtFH2^N437^*~REV~, *AtFH2*~CDSFOR~/*AtFH2^N282^*~REV~ and *AtFH2*~CDSFOR~/*AtFH2^N175^*~REV~ (see [Supplementary File 1](#supp1){ref-type="supplementary-material"}), respectively, using *AtFH2* cDNA as the template. They were subsequently moved into *pBI101-35S:eGFP-NOS* to generate *pBI101-35S:AtFH2^N437^-eGFP-NOS*, *pBI101-35S:AtFH2^N282^-eGFP-NOS* and *pBI101-35S:AtFH2^N175^-eGFP-NOS* plasmids. To determine whether the TM domain of AtFH2 is necessary for its PD localization, the N282 fragment without the TM domain (named as AtFH2^N282^-ΔTMD) was amplified with primer pairs *AtFH2^N282^-ΔTMD*~FOR~/*AtFH2^N282^-ΔTMD*~REV~ and *AtFH2*~CDSFOR~/*AtFH2^N282^*~REV~ using *pBI101-35S:AtFH2^N282^-eGFP-NOS* as the template and the amplified fragment was subsequently moved into *pBI101-35S:eGFP-NOS* to generate *pBI101-35S:AtFH2^N282^-ΔTMD-eGFP-NOS*. To determine whether other Class I *Arabidopsis* formins localize to PD, the N-terminus of *AtFH1*, *AtFH4*, *AtFH6*, *AtFH8*, *AtFH9*, *AtFH10* and *AtFH11* was amplified from WT *Arabidopsis* cDNA using primer pairs *AtFH1(N)*~FOR~/*AtFH1(N)*~REV~, *AtFH4(N)*~FOR~/*AtFH4(N)*~REV~, *AtFH6(N)*~FOR~/*AtFH6(N)*~REV~, *AtFH8(N)*~FOR~/*AtFH8(N)*~REV~, *AtFH9(N)*~FOR~/*AtFH9(N)*~REV~, *AtFH10(N)*~FOR~/*AtFH10(N)*~REV~ and *AtFH11(N)*~FOR~/*AtFH11(N)*~REV~ (see [Supplementary File 1](#supp1){ref-type="supplementary-material"}), respectively. Error-free PCR fragments digested with *Sal*I/*BamH*I were moved into *pBI101-35S:eGFP-NOS* restricted with *Sal*I/*BamH*I to generate the corresponding plasmids. To determine whether some rice Class I formins localize to PD, the N-terminus of Class I OsFH8, OsFH11, OsFH15 and OsFH16 was amplified from *Oryza sativa* Japonica cDNA using primer pairs *OsFH8(N)*~FOR~/*OsFH8(N)*~REV~, *OsFH11(N)*~FOR~/*OsFH11(N)*~REV~, *OsFH15(N)*~FOR~/*OsFH15(N)*~REV~ and *OsFH16(N)*~FOR~/*OsFH16(N)*~REV~ ([Supplementary File 1](#supp1){ref-type="supplementary-material"}), respectively, and the error-free PCR fragments were subsequently moved into *pBI101-35S:eGFP-NOS* restricted with *Xba*I*/BamH*I. The resulting eGFP fusion constructs were transiently expressed in *Nicotiana benthamiana* leaves via *Agrobacterium*-mediated transformation (see below). To indicate the primary cell targeted by particle bombardment, the ER marker HDEL ([@bib3]) was amplified with primers *HDEL-mCherry*~FOR~ and *HDEL-mCherry*~REV~ ([Supplementary File 1](#supp1){ref-type="supplementary-material"}) using the plasmid *1301-Lat52:HDEL-mCherry-NOS* as the template and subsequently moved into a *pdGN* vector to replace eGFP ([@bib32]).

To generate recombinant AtFH2 proteins, three fragments, AtFH2-ΔN, AtFH2-FH1FH2 and AtFH2-FH2, were amplified with primer pairs *AtFH2ΔN*~FOR~/*AtFH2ΔN*~REV~, *AtFH2-FH1FH2*~FOR~/*AtFH2-FH1FH2*~REV~ and *AtFH2-FH2*~FOR~/*AtFH2-FH2*~REV~ ([Supplementary File 1](#supp1){ref-type="supplementary-material"}), respectively, using *AtFH2* cDNA as the template. The amplified fragments were moved into pET28a or pET23a to generate prokaryotic expression plasmids, *pET28a-AtFH2-ΔN*, *pET28a-AtFH2-FH1FH2* and *pET23a-AtFH2-FH2*, respectively. For substitution of isoleucine-519 with alanine (I519A) and lysine-672 with aspartic acid (K672D) in AtFH2-FH2, *AtFH2-FH2* was amplified with primer pairs M5/M6 and M7/M8 ([Supplementary File 1](#supp1){ref-type="supplementary-material"}) using *pEASY-Blunt-AtFH2M* as the template. The amplified fragment, named as *AtFH2-FH2M*, was moved into *pGEX-KG* or *pET23b* to generate *pGEX-KG-AtFH2-FH2M* or *pET23b-AtFH2-FH2M* plasmid. They were transformed into *E. coli* Tuner (DE3) pLysS strain.

Transient expression in *Nicotiana benthamiana* {#s4-4}
-----------------------------------------------

To determine the colocalization of CMV MP with AtFH2, AtFH2M and rice formins, *Agrobacterium*-mediated transient expression was performed in *N. benthamiana*, which was essentially according to the previously published method ([@bib56]). *Agrobacterium tumefaciens* stain GV3101 transformed with *pGD-CMV MP-mCherry* ([@bib53]), *pCambia1301-35S:AtFH2-eGFP-NOS*, *pCambia1301-35S:AtFH2M-eGFP-NOS*, *pBI101-35S:OsFH8(N)-eGFP-NOS*, *pBI101-35S:OsFH11(N)-eGFP-NOS*, *pBI101-35S:OsFH15(N)-eGFP-NOS*, *pBI101-35S:OsFH16(N)-eGFP-NOS* and GV3101 strain carrying p19 were grown at 28°C in Luria Broth culture medium containing 50 μg/mL kanamycin, 50 μg/mL rifampicin, 10 mM MES and 40 μM acetosyringone for 16 hr. Cells were collected by centrifugation and resuspended in 10 mM MgCl~2~ and 200 μM acetosyringone and the cell suspension was adjusted to OD~600~ = 1.0. Cells were left at room temperature for 3 hr. Cultures were mixed with GV3101 transformed with *pGD-CMV MP-mCherry* or p19 and subsequently infiltrated into 3-week-old *N. benthamiana* leaves. *N. benthamiana* leaf epidermal cells were visualized and the images were captured by laser scanning confocal microscopy after 48--60 hr.

Microscopy observation of the localization of AtFH2 {#s4-5}
---------------------------------------------------

The localization of fluorescently tagged proteins was assessed using a laser scanning confocal microscope. eGFP or YFP was excited by a 488 nm argon laser and emission was captured in the range of 505--545 nm. mCherry or propidium iodide (PI) was excited by a 543 nm HeNe laser and emission was captured in the range of 590--625 nm. *Arabidopsis* seedlings were cultured on 1/2 Murashige and Skoog culture medium for 3 to 5 days before being observed under the microscope. For PI staining, *Arabidopsis* seedlings were incubated with 50 μg/mL PI (Sigma-Aldrich, P4864) diluted with the solution containing 9% glucose and 5% glycerol for 5 min at room temperature as described previously ([@bib57]). To demonstrate whether AtFH2 localizes to PD, PD was revealed by staining with aniline blue (see below) or colocalization with CMV MP-mCherry, PDLP1-GFP ([@bib54]) or YFP-PDCB1 ([@bib51]). To simultaneously visualize AtFH2 and actin filaments, GFP-ABD2 marker ([@bib50]) was introduced into *Arabidopsis* plants expressing *pCAMBIA1301-35S:AtFH2-mCherry* by genetic crossing. To determine whether the organization of actin filaments is required for the localization of AtFH2, 7-day-old *Arabidopsis* seedlings were treated with 1 μM latrunculin B for 1 hr before imaging.

Aniline blue staining and quantification {#s4-6}
----------------------------------------

Plasmodesmata was revealed by staining with aniline blue. To observe colocalization of AtFH2 and callose, 7-day-old *Arabidopsis* seedlings were used. To quantify the accumulation of callose at PD, the fifth leaves of 4-week-old *Arabidopsis* were used. Briefly, *Arabidopsis* seedlings or detached leaves were initially treated with a solution containing 300 μM MBS for 30--60 min, which was followed by incubation with aniline blue solution (0.1% aniline blue in double-distilled water and 1 M glycerol, pH 9.5, at a volume ratio of 2:3) for 30 min at room temperature as described previously ([@bib34]; [@bib51]). To quantify the accumulation of callose at PD in WT, *atfh1*, *atfh2* and *atfh1 atfh2* plants, confocal images were subjected to intensity analysis using ImageJ software (<http://rsbweb.nih.gov/ij/>; version 1.51) as described previously ([@bib51]). The average fluorescence intensity and the size of the aniline blue-stained callose foci were measured and compared between WT and formin loss-of-function mutants. For each genotype, more than 100 data sets were collected from at least 20 separate images. As the data did not show a normal distribution, statistical comparison between different genotype was performed with a Mann-Whitney U test using IBM SPSS Statistics version 25 software.

Visualization and quantification of the organization of actin filaments in *Arabidopsis* leaf epidermal cells {#s4-7}
-------------------------------------------------------------------------------------------------------------

To capture the organization of actin filaments in leaf epidermal cells, 7-day-old *Arabidopsis* seedlings expressing *35S:GFP-ABD2* were observed under a laser scanning confocal microscope and the Z series images were collected with the step size set at 0.5 μm. The density of actin filaments in the leaf epidermal cells was determined by measuring the value of occupancy as described previously ([@bib27]). Briefly, the Z-stack images were converted to binary images by thresholding and were subsequently skeletonized and processed with maximum intensity projection. The occupancy is determined as the proportion of the pixels representing filaments out of the total pixels in the selected region. More than 50 data sets were collected from at least 10 plants for each genotype. All measurements and image processing were performed by ImageJ software (version 1.51 s, <http://imagej.nih.gov/ij>).

Observation of cytoplasmic streaming {#s4-8}
------------------------------------

Cytoplasmic streaming was quantified according to the method described previously ([@bib43]). The hypocotyl cells were observed in a bright ﬁeld under an IX71 microscope (Olympus) equipped with a × 40 objective. Digital images were collected at 1 s intervals for 10--15 min with a Retiga Exi Fast 1394 CCD camera (QImaging) using Image-Pro Express 6.3 software. For estimation of the velocity, more than 50 data sets were collected from at least five plants for each genotype. The moving plastids were randomly selected and measured using ImageJ software.

Assays for diffusion of GFP and cell-to-cell movement of CMV MP-GFP {#s4-9}
-------------------------------------------------------------------

Cell-to-cell trafficking was examined by determining the diffusion of eGFP across cells or the cell-to-cell movement of CMV MP-eGFP, which is described in more detail at Bio-protocol ([@bib16]). In brief, the transient expression of eGFP or CMV MP-eGFP was achieved by a biolistic DNA delivery system in *Arabidopsis* leaves. Bombardment of leaves with plasmid DNA was performed basically as described by [@bib36] with slight modifications. Briefly, approximately 2 μg of plasmid DNA were mixed with 0.5 mg gold particles (diameter, 1 μm, Bio-Rad) in the presence of 20 μL of fresh N-\[3-aminopropyl\]−1,4-butanediamine (spermidine) (0.1 M) and 50 μL of CaCl~2~ (2.5 M) before vortexing uninterruptedly for 3 min. The mixture was centrifuged for 10 s before precipitating for 5 min. The pellet was subsequently washed with 70% ethanol and absolute ethanol, and finally resuspended in 15 μL absolute ethanol. Rosette leaves from 3-week-old *Arabidopsis* plants which had not yet bolted were placed in a petri dish containing 20 mL of MS medium with 0.8% agar before bombardment. The target leaf was placed at a distance of 12 cm from the gene gun. The leaves were incubated for 24 hr or 48 hr at 23°C in the dark. To quantify the number of layers of cells into which eGFP diffused, images of eGFP in the lower epidermis cells were captured by a Zeiss LSM 510 META at 24 hr and 48 hr. Statistical analysis was performed as described by [@bib34]. The cell that was transformed by DNA bombardment was defined as layer 0, and the cells that share a common cell wall with layer 0 were defined as layer 1. Cells that share a common cell wall with layer 1 cells, but not with layer 0 cells, were defined as layer 2 cells. Cells that expressed GFP but showed no diffusion were not counted to avoid the situation in which damage was caused by the bombardment. To indicate the bombarded cell, *pdGN-35S:HDEL-mCherry* plasmid was used for bombardment along with the *pdGN* plasmid expressing eGFP. Both *pdGN* and *pdGN-35S:HDEL-mCherry* plasmids at 2 μg were mixed with 1 μm gold particles (Bio-Rad) for the bombardment. Results were analyzed with the nonparametric Mann-Whitney U test using IBM SPSS Statistics version 25 software.

Fny-CMV inoculation and quantification of infection in *Arabidopsis* leaves {#s4-10}
---------------------------------------------------------------------------

Fny-CMV infected *N. benthamiana* leaves were used for virus purification. After 7 days, the extract of virions at a concentration of 100 μg/ml was rub inoculated onto *Arabidopsis* seedlings at the 5--6 true-leaf stage ([@bib18]). The extent of infection was assessed by determining the amount of CMV *MP* RNA and quantifying the morphology of leaves. To detect the amount of CMV *MP* RNA in plants, a quantitative RT-PCR was performed. Primers Oligo (dT)~18~ and CMV *MP*~REV~ were used to reverse transcribe plant total RNA and RNA of CMV *MP* respectively. Primer pairs CMV *MP*-RT~FOR~/CMV *MP*-RT~REV~ ([Supplementary File 1](#supp1){ref-type="supplementary-material"}) were used to determine the transcript levels of CMV *MP*. The relative amount of CMV *MP* transcripts was quantified using the 2^-ΔΔCt^ method with *eIF4A* as the internal control.

Protein purification {#s4-11}
--------------------

AtFH2-FH2, AtFH2-FH1FH2, AtFH2ΔN and AtFH2-FH2M either fused with GST or 6 × His were expressed in the *E. coli* Tuner (DE3) pLysS strain by induction with 0.4 mM isopropyl β-D-thiogalactopyranoside overnight at 16°C. *E. coli* cells were collected by centrifugation at 6000 rpm (Beckman JA-10), and resuspended either in 1 × PBS (140 mM NaCl, 2.7 mM KCl, 10 mM Na~2~HPO4, 1.8 mM KH~2~PO4) or in 1 × binding buffer (25 mM Tris-HCl, pH 8.0, 250 mM KCl, 5 mM imidazole, 2 mM DTT) with proteinase inhibitor cocktail for the purification of GST fusion proteins or His-tag fusion proteins. After sonication and centrifugation at 27,216 g for 30 min, the supernatant was incubated with glutathione-sepharose (Amersham) or Ni-NTA resin (Novagen), using purification procedures according to the manufacturers' instructions. All purified proteins were dialyzed against 5 mM Tris-HCl, pH 8.0, 5% glycerol, flash frozen in liquid nitrogen, and stored at −80°C. They were preclarified at 200,000 g for 30 min at 4°C before the subsequent analyses. Actin was isolated from acetone powder of rabbit skeletal muscle ([@bib52]). Monomeric Ca-ATP-actin was subsequently purified by chromatography on Sephacryl S-300 at 4°C in Buffer G (5 mM Tris-HCl, pH 8.0, 0.2 mM ATP, 0.1 mM CaCl~2~, 0.5 mM DTT, 0.1 mM NaN~3~) ([@bib46]). Actin was labeled on Cys-374 with pyrene iodoacetamide to monitor the kinetic process of actin polymerization and depolymerization ([@bib46]) or labeled with Oregon-green as described previously ([@bib2]). Human profilin I was purified as described previously ([@bib21]), and AtFH1-FH1FH2 was purified according to [@bib40].

Actin nucleation assay {#s4-12}
----------------------

The actin nucleation assay procedure was performed as described previously ([@bib28]). Mg-ATP-actin or actin-profilin complexes (3 μM, 10% pyrene labeled) were incubated with various concentrations of AtFH2 for 3 min at room temperature before the addition of one-tenth volume of 10 × KMEI (500 mM KCl, 10 mM MgCl~2~, 10 mM EGTA, 100 mM imidazole-HCl, pH 7.0). Polymerization of actin was traced by monitoring pyrene fluorescence by a QuantaMaster Luminescence QM 3 PH fluorometer (Photo Technology International, Inc.) with the excitation and emission wavelengths set at 365 nm and 407 nm, respectively.

Seeded actin elongation assay {#s4-13}
-----------------------------

A seeded actin elongation assay, to determine the affinity of AtFH2 for the barbed end of actin filaments, was performed roughly according to the method described previously ([@bib29]). Actin filaments at a final concentration of 0.8 μM were incubated for 3 min at room temperature with various concentrations of AtFH2. Actin elongation was initiated by the addition of actin-profilin complexes (1 μM, 10% pyrene labeled) to the actin filament mixture. The equilibrium binding constant (*K*~d~) of AtFH2 proteins for the barbed end of actin filaments was determined by plotting the initial elongation rate as a function of the concentration of AtFH2 proteins using the following equation:$$\text{V}_{\text{i}}\text{=}\text{V}_{\text{if}}\text{+}\left( {\text{V}_{\text{ib}} - \text{V}_{\text{if}}} \right)\left( \frac{\text{K}_{\text{d}}\text{+}\left\lbrack \text{ends} \right\rbrack\text{+}\left\lbrack \text{AtFH2} \right\rbrack - \sqrt{\left( {\text{K}_{\text{d}}\text{+}\left\lbrack \text{ends} \right\rbrack\text{+}\left\lbrack \text{AtFH2} \right\rbrack} \right)^{\text{2}} - \text{4}\left\lbrack \text{ends} \right\rbrack\left\lbrack \text{AtFH2} \right\rbrack}}{\text{2}\left\lbrack \text{ends} \right\rbrack} \right)$$where V~i~ is the observed rate of elongation, V~if~ is the rate of elongation when all the barbed ends are free, V~ib~ is the rate of elongation when all the barbed ends are capped, \[ends\] is the concentration of barbed ends, and \[AtFH2\] is the concentration of AtFH2. The data were modeled with KaleidaGraph software (version 4.03, <http://kaleidagraph.software.informer.com/>).

Actin depolymerization assay {#s4-14}
----------------------------

The dilution-mediated actin depolymerization assay was performed as described previously ([@bib29]). 5 μM F-actin (50% pyrene-labeled) was incubated with various concentrations of AtFH2 for 3 min at room temperature before being diluted 25-fold into Buffer G. Actin depolymerization was traced by monitoring the changes in pyrene fluorescence by a QuantaMaster Luminescence QM 3 PH fluorometer (Photo Technology International, Inc.) with the excitation and emission wavelengths set at 365 nm and 407 nm, respectively.

Fluorescence light microscopy of actin filaments {#s4-15}
------------------------------------------------

The annealing of actin filaments was visualized and quantified by fluorescence light microscopy as described previously ([@bib29]). Briefly, actin filaments were labeled with equimolar rhodamine-phalloidin (Sigma-Aldrich) and then they were broken by sonication in the absence or presence of different concentrations of AtFH2. After incubation for a certain period of time, actin filaments were visualized under an Olympus IX71 microscope equipped with a × 60, 1.42--numerical aperture oil objective and the images were acquired by a Retiga EXi Fast 1394 CCD camera (QImaging) with Image-Pro Express 6.3 software. The effect of AtFH2 on actin filament annealing was quantified by measuring the length of actin filaments.

Direct visualization of actin filament dynamics by total internal reflection fluorescence microscopy (TIRFM) {#s4-16}
------------------------------------------------------------------------------------------------------------

The effect of AtFH2 on the dynamics of single actin filaments was determined by TIRFM as described previously ([@bib64]). The effect of AtFH2 on actin nucleation was analyzed by counting the number of actin filaments within microscope fields, and the effect of AtFH2 on the growth of actin filaments was analyzed by performing kymograph analysis by tracing the elongating end of actin filaments using ImageJ software (<http://rsbweb.nih.gov/ij/>; version 1.51).

Size exclusion chromatography {#s4-17}
-----------------------------

Size exclusion chromatography was performed to determine the size of AtFH2-FH2 and AtFH2-FH2M. Protein samples in 1 mL of running buffer (100 mM Tris-HCl, pH 8.5, 150 mM NaCl, 1 mM DTT and 5% glycerol) were loaded onto a Superdex 200 Increase 10/300 gel ﬁltration column (GE) pre-equilibrated with running buffer, and the column was run at the speed of 0.4 mL/min with running buffer. Protein fractions of 0.5 ml were collected and separated by SDS-PAGE. Molecular weights were determined according to the manufacturer's instructions.

Statistical analyses {#s4-18}
--------------------

The statistical analysis of the datasets was performed using IBM SPSS Statistics version 25 software. The normality of the datasets was initially assessed by Shapiro-Wilk tests. If the data were normally distributed, the Student's t-test was applied for the subsequent statistical analyses. However, if the data were not normally distributed, the Mann-Whitney U test was applied for the subsequent statistical analyses. Differences were considered significant when p\<0.05 and differences were considered extremely significant when p\<0.01. The statistical tests and number of replicates are provided in the figure legend.
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In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

Thank you for submitting your article \"*Arabidopsis* Formin 2 Regulates Cell-to-Cell Trafficking by Capping and Stabilizing Actin Filaments at Plasmodesmata\" for consideration by *eLife*. Your article has been reviewed Christian Hardtke as the Senior Editor, a Reviewing Editor, and three reviewers. The reviewers have opted to remain anonymous.

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

This manuscript presents the finding that several *Arabidopsis* Class I formins localise to plasmodesmata. Focusing on AtFH2 (targeted to plasmodesmata by its transmembrane domain) the authors find that it does not nucleate actin filaments but rather caps and stabilises actin filaments. AtFH1 is a known nucleator of actin filaments but also localises to plasmodesmata. Both AtFH2 and AtFH1 play a role in the regulation of the movement of GFP and are more susceptible to CMV infection, and mutants in both formins show greater movement of CMV MP between cells. The authors ultimately propose a model in which F-actin is present in the cytoplasmic sleeve of plasmodesmata, anchored by AtFH2. They propose that loss of the AtFH2 anchor increases the movement of GFP between cells by simply removing a physical blockage caused by F-actin. This manuscript presents a new actin-associated protein that associates at plasmodesmata, adding to actin, myosin, NET1A and Arp3. The authors have elegantly shown that AtFH1 and AtFH2 have nucleation/assembly and capping roles respectively, suggesting that there is specific regulation of F-actin at plasmodesmata.

Summary:

The authors present convincing data that the At formin proteins localize to the plasmodesmata and play a role in controlling size exclusion. The work appears to be well done but the results are over interpreted, especially with regard to the models that they draw from their data.

Essential revisions:

The manuscript was reviewed by three knowledgeable reviewers. The consensus was that the paper would be suitable for publication if some revisions were made and a few additional experiments completed. Perhaps the strongest, negative comments related to the model proposed with regard to AtFH2. The feeling was that this model was not well supported by the data presented. Here are some of the specific comments made by the reviewers that relate to this:

The model in Figure 7J suggests there are multiple F-actin filaments in the cytoplasmic sleeve of a plasmodesma. Given that F-actin has a diameter of \~6nm, and a cytoplasmic sleeve might be only \~10-20nm at its widest point (doi:10.1038/nplants.2017.82), this seems an unlikely model. The authors say they can\'t directly visualise actin in plasmodesmata, but new advances in high resolution live imaging, or electron microscopy, would allow the domain of localisation of AtFH2 (within the plasmodesma or at the neck) to be assessed. It would further allow the abundance of actin in plasmodesmata to be assessed in the *atfh2* mutant. The model needs better justification, or other models should be considered.

There is no investigation or discussion of what the role of AtFH2 and actin in plasmodesmata is. Simply blocking up the channel doesn\'t relate to structure or function of plasmodesmata in any specific way.

Hence, we suggest removing the model completely from the paper or, at least, toning it down considerably by offering alternative explanations that also fit the dataset.

Additional major concerns with the paper are as follows:

1\) PD callose is also one of the key factors involved in modulating PD SEL. Have authors checked the PD callose level in different genotypes, single and double mutants along with wild type? It is known that GFP movement from cell to cell can be regulated by callose deposition, does AtFH2 affect this? It\'s also known that actin regulates cyoplasmic streaming which would influence rate of GFP \'diffusion\' between cells, does AtFH2 affect cytoplasmic streaming?

2\) The experiment in which the *atfh2* mutant is complemented by plasmodesmata-targeted FIMBRIM 5 seems confounded. FIM5 and AtFH2 are functionally different -- while a similar phenotype may be observed no conclusions can be drawn regarding the mode of action of AtFH2 at plasmodesmata. Show localisation of PDFIM5.

3\) Provide the control showing the arrangement of actin filaments when AtFH2 is ectopically expressed. Please provide information whether AtFH2 over-expression lines showing any PD trafficking-related phenotype?

4\) Authors have used the truncated domain for checking the biochemical properties of AtFH2, I wonder whether these domains individually complement the *atfh2* phenotype in planta. How we know whether this AtFH2△N function in the same way with membrane attached full-length FH2? A related question...is the TM domain sufficient to target proteins to the PD and, if yes, is it also sufficient for the phenotypes seen?

5\) The bombardment experiments should have been executed with a non-mobile fluorescent protein that marks the bombarded cell to ensure that movement is correctly interpreted. If the authors have not done this, we recognise that this would require the data set to be entirely repeated. Therefore, we suggest the following alternative experiment -- that the authors provide a control dataset in which the bombardments are performed with and without a transformation marker (e.g. ER-RFP) to provide supporting evidence that misinterpretation of movement is not frequent under their experimental conditions.

\[Editors\' note: further revisions were requested prior to acceptance, as described below.\]

Thank you for resubmitting your work entitled \"*Arabidopsis* Formin 2 Regulates Cell-to-Cell Trafficking by Capping and Stabilizing Actin Filaments at Plasmodesmata\" for further consideration at *eLife*. Your revised article has been favorably evaluated by Christian Hardtke (Senior Editor), a Reviewing Editor, and two reviewers.

The manuscript has been improved but there are some remaining issues that need to be addressed before acceptance, as outlined below:

*Reviewer \#2*:

I am happy to see the manuscript revised appropriately according to editor\'s and reviewers\' comments. I have no any major comments.

*Reviewer \#3*:

The revised manuscript from Diao et al., has addressed many of my comments and I think it reads well. I am pleased to see they have removed the model. However, some of the points included in the list of concerns have not been addressed and I hope they are before the paper is accepted.

\- I am not convinced by the authors' argument for including the PDFIM5 experiment. I still consider the experiment is confounded because: (1) the authors have not experimentally shown that PDFIM5 stabilises actin filaments; (2) FIM and AtFH2 function in very different ways and as they haven\'t demonstrated that both proteins influence the actin at plasmodesmata in the same way they can\'t draw the conclusion that both proteins influence plasmodesmata by the same process. In my opinion, removing this experiment from the paper does not weaken it.

\- The authors have not addressed the comment that AtFH1 and AtFH2 are not redundant; it is still mentioned in the Abstract that they are and I consider this incorrect interpretation of the data they present. Given that the *atfh1* and *atfh2* single mutants both exhibit phenotypes, and that AtFH1 and AtFH2 have different biochemical functions, the authors can only conclude that they are partially redundant (if at all). With respect to the claim that AtFH1 has capping activity the authors refer to Michelot et al., 2005. This paper makes the statement \"The FH2-Cter domain acts like an efficient capper and blocks elongation at the barbed end of actin filaments. However, the presence of the FH1 domain allows the FH1-FH2-Cter protein to bind the barbed ends and allow elongation at the barbed ends.\" This implies to me that the full length AtFH1 does not have good capping activity, and therefore that AtFH1 and AtFH2 are unlikely to be fully redundant.

\- The authors are also still referring to CMV MP-GFP movement from cell-to-cell as diffusion. CMV MP-GFP clearly localises at plasmodesmata and is therefore not freely mobile or \'diffusing\' in the cell. It is well accepted that viral MPs are active and specific in their translocation from cell to cell via plasmodesmata. The use of the term diffusion here is incorrect and I recommend changing it to cell-to-cell movement CMV MP-GFP.

\- The authors have changed their statistical tests for data they state is not normal. However, details of the test they used to identify that the data are not normal have not been supplied.

\- The source files are simply tables that contain the results from the analysis of the data, not the raw data. They offer nothing new that isn\'t in the manuscript other than a p-value.

10.7554/eLife.36316.061

Author response

> The manuscript was reviewed by three knowledgeable reviewers. The consensus was that the paper would be suitable for publication if some revisions were made and a few additional experiments completed. Perhaps the strongest, negative comments related to the model proposed with regard to AtFH2. The feeling was that this model was not well supported by the data presented. Here are some of the specific comments made by the reviewers that relate to this:
>
> The model in Figure 7J suggests there are multiple F-actin filaments in the cytoplasmic sleeve of a plasmodesma. Given that F-actin has a diameter of \~6nm, and a cytoplasmic sleeve might be only \~10-20nm at its widest point (doi:10.1038/nplants.2017.82), this seems an unlikely model. The authors say they can\'t directly visualise actin in plasmodesmata, but new advances in high resolution live imaging, or electron microscopy, would allow the domain of localisation of AtFH2 (within the plasmodesma or at the neck) to be assessed. It would further allow the abundance of actin in plasmodesmata to be assessed in the atfh2 mutant. The model needs better justification, or other models should be considered.

We used super resolution Structured Illumination Microscopy (SIM) to determine the localization of AtFH2, but we failed to obtain useful additional information compared to that previously captured by laser scanning confocal microscopy. This is very likely because the size of PD (with a length of about 150 nm across cells and a width of roughly about 20-30 nm) is too small to be imaged by SIM (which has a resolution of about 85 nm). Therefore, SIM cannot yield any useful information in terms of the precise localization of AtFH2. We also attempted to determine the localization of AtFH2 with immunogold electron microscopy using anti-GFP antibody, but it did not work well in our hands.

In addition, we found that it is almost impossible to specifically visualize actin filaments at PD with SIM because actin filaments are very dense at the border of cells (see Figure 1---figure supplement 2C; Figure 2---figure supplement 3C). Therefore, we do not have direct evidence to judge whether the density of actin filaments is reduced at PD in *atfh2* mutants. We agree that, with the current set of data, the model is not fully supported, and we therefore deleted the model in this revised manuscript. Accordingly, we rewrote the statement about the potential function of AtFH2 in regulating actin dynamics at PD in the text (Introduction; Discussion section.

> There is no investigation or discussion of what the role of AtFH2 and actin in plasmodesmata is. Simply blocking up the channel doesn\'t relate to structure or function of plasmodesmata in any specific way.

Our data suggest that the amount of actin filaments and/or their stability is crucial for the permeability of PD. Besides speculating that actin filaments might function as the barrier in blocking cell-to-cell trafficking as proposed previously, we really do not know how AtFH2 and actin might play any specific role in regulating the permeability of PD. Given that the reconstructed ultrastructure of PD using electron tomography showed that the contact between the PM and ER is highly dynamic and might be crucial for the permeability of PD (doi:10.1038/nplants.2017.82), we speculate that AtFH2-tethered actin filaments might be involved in regulating the contact between PM and ER. The detailed information can be found in the Discussion section.

> Hence, we suggest removing the model completely from the paper or, at least, toning it down considerably by offering alternative explanations that also fit the dataset.

We totally agree with the comments that it is inappropriate to fit more actin filaments (with their diameter of about 7 nm) into the cytoplasmic sleeves of PD (with its diameter of less than 10 nm) (doi:10.1038/nplants.2017.82). Considering this along with the fact that we do not know exactly where AtFH2 is localized in PD, we decide to remove the model. Accordingly, we modified our statement about the potential function of AtFH2 and actin at PD. In this revised manuscript, we simply argue that AtFH2-mediated stability of actin filaments and/or the amount of actin filaments at PD might be crucial for the regulation of SEL of PD.

> 1\) PD callose is also one of the key factors involved in modulating PD SEL. Have authors checked the PD callose level in different genotypes, single and double mutants along with wild type? It is known that GFP movement from cell to cell can be regulated by callose deposition, does AtFH2 affect this? It\'s also known that actin regulates cyoplasmic streaming which would influence rate of GFP \'diffusion\' between cells, does AtFH2 affect cytoplasmic streaming?

We performed callose staining for WT and *atfh2, atfh1* and *atfh1fh2* mutants, and found that there is no dramatic difference in the accumulation of callose at PD between formin loss-of-function mutants and WT (see the results in the newly prepared Figure 4---figure supplement 2). In addition, we determined the velocity of cytoplasmic streaming in *Arabidopsis* hypocotyl cells and found that it is similar between WT and *atfh2* mutants, which suggests that the increase in SEL of PD does not result from the changes in intracellular trafficking (see the results in the newly prepared Figure 2figure supplement 2).

> 2\) The experiment in which the atfh2 mutant is complemented by plasmodesmata-targeted Fimbrin5 seems confounded. FIM5 and AtFH2 are functionally different -- while a similar phenotype may be observed no conclusions can be drawn regarding the mode of action of AtFH2 at plasmodesmata. Show localisation of PDFIM5.

Based on our in vitro biochemical results that AtFH2 caps and stabilizes actin filaments, we speculated that the stability and/or the amount of actin filaments at PD are reduced in *atfh2* mutants. In this regard, we hypothesized that if we could prevent the depolymerization of actin filaments in PD, we might be able to suppress the cell-to-cell trafficking phenotype in *atfh2*. We tested this hypothesis by introducing a PD-targeting actin filament stabilizer. We fused the PD-targeting N-terminus of AtFH2 with an actin filament stabilizer FIM5 and found that the fusion protein called PD-FIM5 indeed targets to PD (Figure 7I). We found that introduction of PDFIM5 into *atfh2* suppressed the cell-to-cell trafficking phenotype, which suggests that the cell-to-cell trafficking phenotype in *atfh2* mutants indeed results to some extent from the instability of actin filaments at PD.

> 3\) Provide the control showing the arrangement of actin filaments when AtFH2 is ectopically expressed. Please provide information whether AtFH2 over-expression lines showing any PD trafficking-related phenotype?

We found that overexpression of *AtFH2* does not have an overt effect on the organization of actin filaments and cell-to-cell trafficking (see the results in the newly prepared Figure 2---figure supplement 3).

> 4\) Authors have used the truncated domain for checking the biochemical properties of AtFH2, I wonder whether these domains individually complement the atfh2 phenotype in planta. How we know whether this AtFH2△N function in the same way with membrane attached full-length FH2? A related question...is the TM domain sufficient to target proteins to the PD and, if yes, is it also sufficient for the phenotypes seen?

The actin-related function of formin proteins is determined by the FH1FH2 domain. Therefore, colleagues in this field have routinely analyzed the biochemical activity of the formin FH1FH2 domain in regulating actin dynamics in vitro in order to understand the biochemical activity of formin proteins in regulating actin dynamics. In this regard, the FH1FH2 domain can to some extent represent the full-length protein in terms of the activity in regulating actin dynamics.

We demonstrate that the TM domain of AtFH2 is sufficient and necessary for the targeting of AtFH2 to PD (Figure 1). In further support of this notion, we found that the TM domain-containing N-terminus of AtFH2 is able to direct the heterologous *Arabidopsis* FIM5 to PD (Figure 7I). However, we found that simply targeting AtFH2 to PD is not sufficient for its function, since AtFH2M is able to target to PD but fails to rescue the cell-to-cell trafficking phenotype in *atfh2*.

> 5\) The bombardment experiments should have been executed with a non-mobile fluorescent protein that marks the bombarded cell to ensure that movement is correctly interpreted. If the authors have not done this, we recognise that this would require the data set to be entirely repeated. Therefore, we suggest the following alternative experiment -- that the authors provide a control dataset in which the bombardments are performed with and without a transformation marker (e.g. ER-RFP) to provide supporting evidence that misinterpretation of movement is not frequent under their experimental conditions.

As suggested, we performed the bombardments using the eGFP-expressing plasmid *pdGN* along with a plasmid expressing the non-mobile HDEL-mCherry (*pdGN-35S:HDEL-mCherry*). We found that the HDEL-mCherry signal mostly stays in one cell while the eGFP signal appears in other cells besides the cell containing the HDEL-mCherry signal. We conclude that the cell having the non-mobile HDEL-mCherry signal is the bombarded cell. Therefore, the eGFP signal in the surrounding cells results from diffusion. We repeated the eGFP diffusion experiments using HDEL-mCherry to indicate the bombarded cell and compared the PD permeability between WT and the formin loss-of-function mutants and obtained the same results as before (see the results in the newly prepared Figure 2---figure supplement 1).

\[Editors\' note: further revisions were requested prior to acceptance, as described below.\]

> The manuscript has been improved but there are some remaining issues that need to be addressed before acceptance, as outlined below:
>
> Reviewer \#3:
>
> \[...\] - I am not convinced by the authors' argument for including the PDFIM5 experiment. I still consider the experiment is confounded because: (1) the authors have not experimentally shown that PDFIM5 stabilises actin filaments; (2) FIM and AtFH2 function in very different ways and as they haven\'t demonstrated that both proteins influence the actin at plasmodesmata in the same way they can\'t draw the conclusion that both proteins influence plasmodesmata by the same process. In my opinion, removing this experiment from the paper does not weaken it.

FIM5 was previously demonstrated to stabilize actin filaments in vitro (Wu et al., 2010), which allows us to speculate that PD-FIM5 will stabilize actin filaments at PD since it is indeed directed to PD by its N-terminal PD targeting sequence. Although AtFH2 and PD-FIM5 act through different mechanisms, we could speculate that both proteins will stabilize actin filaments and influence the amount of actin filaments at PD. However, we cannot currently demonstrate that both proteins influence PD by the same process. Therefore, for clarity, we removed the data as suggested. We also removed the related information in the Results section, legends, Materials and methods section and primer list sections.

> \- The authors have not addressed the comment that AtFH1 and AtFH2 are not redundant; it is still mentioned in the Abstract that they are and I consider this incorrect interpretation of the data they present. Given that the atfh1 and atfh2 single mutants both exhibit phenotypes, and that AtFH1 and AtFH2 have different biochemical functions, the authors can only conclude that they are partially redundant (if at all). With respect to the claim that AtFH1 has capping activity the authors refer to Michelot et al., 2005. This paper makes the statement \"The FH2-Cter domain acts like an efficient capper and blocks elongation at the barbed end of actin filaments. However, the presence of the FH1 domain allows the FH1-FH2-Cter protein to bind the barbed ends and allow elongation at the barbed ends.\" This implies to me that the full length AtFH1 does not have good capping activity, and therefore that AtFH1 and AtFH2 are unlikely to be fully redundant.

We agree with this reviewer that AtFH1 and AtFH2 are only partially redundant in terms of their biochemical activities in regulating actin dynamics. We therefore modified our statement accordingly.

> \- The authors are also still referring to CMV MP-GFP movement from cell-to-cell as diffusion. CMV MP-GFP clearly localises at plasmodesmata and is therefore not freely mobile or \'diffusing\' in the cell. It is well accepted that viral MPs are active and specific in their translocation from cell to cell via plasmodesmata. The use of the term diffusion here is incorrect and I recommend changing it to cell-to-cell movement CMV MP-GFP.

We fixed the problem throughout the manuscript.

> \- The authors have changed their statistical tests for data they state is not normal. However, details of the test they used to identify that the data are not normal have not been supplied.

We initially assessed the datasets with Shapiro-Wilk tests to see whether they have a normal distribution. We have now included this test information in the source data and we also added a statement about how we performed the statistical analysis in the Materials and methods section.

> \- The source files are simply tables that contain the results from the analysis of the data, not the raw data. They offer nothing new that isn\'t in the manuscript other than a p-value.

Sorry, we overlooked this question during the last revision, and we have now included the raw data. We also explained that we used Shapiro-Wilks tests to assess the datasets to see whether they have a normal distribution. We have included this information in the newly prepared source data.
